FeatureID,Name,Formula,MW,KEGG.Pathways,name4plot,C,H,O,NA.,F,N,Cl,P,S,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature0042,NA,NA,243.07186,NA,Feature0042,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.55260989,27.68394185,1.284482111,0.361186798,0.018712295,0.215273855,Upregulated
Feature0335,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,3,0,0,1,0,0,0,1.3,0.3,-0.4,71.7,5,2,0.166666667,0.333333333,1,Phenol,25.34960583,32.47113855,1.28093268,0.357194657,0.029858148,0.245104196,Upregulated
Feature0487,(±)13-HpODE,C18 H32 O4,294.21938,Metabolic pathways;Biosynthesis of secondary metabolites;Other,(±)13-HpODE,18,32,4,0,0,0,0,0,0,1.777777778,0.222222222,-1.333333333,98.3,3,-1,-0.071428571,0.0625,-1,Lipid,21.37695355,26.75474521,1.2515696,0.323738522,0.018281837,0.215273855,Upregulated
Feature0304,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,6,0,0,1,0,0,0,1.888888889,0.666666667,-0.222222222,66.63333333,2,-4,-2.5,-0.4,-5,Amino Sugar,21.80748654,27.22839814,1.248580303,0.320288612,0.052561666,0.26375688,Upregulated
Feature0361,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,4,0,0,7,0,0,0,1.571428571,0.571428571,2.571428571,-12.98571429,6,2,1.25,1.5,-5,Amino Sugar,21.6516897,27.02757975,1.248289631,0.319952711,0.047294789,0.26375688,Upregulated
Feature0460,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]",NA,172.07118,NA,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]-peak2",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.56738806,26.86884909,1.245809136,0.317083058,0.062656319,0.26375688,Upregulated
Feature0036,NA,NA,188.06609,NA,Feature0036,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.18962228,27.63396818,1.245355501,0.316557635,0.054234588,0.26375688,Upregulated
Feature0091,Phenacetin isomer 1,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin isomer 1,10,13,2,0,0,1,0,0,0,1.3,0.2,-0.6,77.4,5,3,0.285714286,0.375,2,Phenol,24.81092306,30.71724233,1.238053185,0.308073292,0.021718387,0.221205796,Upregulated
Feature0039,NA,NA,792.22295,NA,Feature0039,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.62335566,25.51822781,1.237346057,0.307249045,0.078325968,0.26375688,Upregulated
Feature0251,Beauvericin,C45 H57 N3 O9,805.39159,NA,Beauvericin,45,57,9,0,0,3,0,0,0,1.266666667,0.2,-0.666666667,79.3,19,10,0.212121212,0.306666667,7,Phenol,23.76799807,29.33174214,1.234085515,0.303442369,0.05590277,0.26375688,Upregulated
Feature0122,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,0,0,0,6,0,0,0,1,0,0.285714286,52.15714286,11,11,0.625,0.625,5,Unsaturated HC,21.88259205,26.91525689,1.229984859,0.298640556,0.066692487,0.26375688,Upregulated
Feature0548,NA,C14 H10 F N O2,243.07186,NA,Feature0548,14,10,2,0,1,1,0,0,0,0.714285714,0.142857143,-0.214285714,66.40714286,10.5,8.5,0.681818182,0.708333333,7.5,Condensed HC,22.74430698,27.86875159,1.225306694,0.2931429,0.090511294,0.272814166,Upregulated
Feature0544,NA,C14 H10 F N O2,221.08991,Metabolic pathways;ABC transporters;Other,Feature0544,14,10,2,0,1,1,0,0,0,0.714285714,0.142857143,-0.214285714,66.40714286,10.5,8.5,0.681818182,0.708333333,7.5,Condensed HC,23.01203731,28.06720732,1.219675031,0.286496809,0.01363909,0.197407885,Upregulated
Feature0401,[Similar to: Beauvericin],C45 H57 N3 O9,800.43625,NA,[Similar to: Beauvericin]-peak1,45,57,9,0,0,3,0,0,0,1.266666667,0.2,-0.666666667,79.3,19,10,0.212121212,0.306666667,7,Phenol,23.93734229,29.19061052,1.219459127,0.286241403,0.054643242,0.26375688,Upregulated
Feature0402,[Similar to: Beauvericin],C45 H57 N3 O9,783.4096,NA,[Similar to: Beauvericin]-peak2,45,57,9,0,0,3,0,0,0,1.266666667,0.2,-0.666666667,79.3,19,10,0.212121212,0.306666667,7,Phenol,24.45970991,29.81792641,1.219062962,0.28577264,0.04897966,0.26375688,Upregulated
Feature0272,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,0,0,0,1,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258065,0.532258065,16.5,Unsaturated HC,23.47436302,28.55321687,1.216357473,0.282567282,0.07409962,0.26375688,Upregulated
Feature0541,NA,C14 H10 F N O2,243.07186,NA,Feature0541,14,10,2,0,1,1,0,0,0,0.714285714,0.142857143,-0.214285714,66.40714286,10.5,8.5,0.681818182,0.708333333,7.5,Condensed HC,22.23753499,26.9024831,1.209778112,0.274742464,0.091108509,0.272814166,Upregulated
Feature0210,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,2,0,0,1,0,0,0,1.857142857,0.285714286,-0.857142857,84.72857143,2,0,-0.25,0,-1,Lipid,23.81793483,28.67128729,1.203768819,0.267558353,0.046234814,0.26375688,Upregulated
Feature0138,MFCD00634809 ChemSpider,C16 H20 N2 O3,288.14736,NA,MFCD00634809 ChemSpider,16,20,3,0,0,2,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.272727273,0.36,3,Phenol,22.71978788,27.24553597,1.199198519,0.262070506,0.068899947,0.26375688,Upregulated
Feature0490,"?,?'-diglycerol",C6 H14 O5,166.08414,NA,"?,?'-diglycerol",6,14,5,0,0,0,0,0,0,2.333333333,0.833333333,-0.666666667,79.3,0,-5,-5,-0.714285714,-5,Carbohydrate,23.20603239,27.80219427,1.198058927,0.26069887,0.070711578,0.26375688,Upregulated
Feature0515,NA,C12 H15 N3 S,233.10278,NA,Feature0515,12,15,0,0,0,3,0,0,1,1.25,0,-0.333333333,69.8,7,7,0.375,0.375,3,Unsaturated HC,21.52345622,25.75287603,1.196502818,0.258823795,0.068232588,0.26375688,Upregulated
Feature0461,"[Similar to: 1,4:3,6-Dianhydro-2,5-dideoxy-2-{5-[3-(dimethylamino)phenoxy]-1H-tetrazol-1-yl}-5-[(1-naphthylcarbamoyl)amino]-L-iditol; ΔMass: -343.1569 Da]",NA,158.05552,NA,"[Similar to: 1,4:3,6-Dianhydro-2,5-dideoxy-2-{5-[3-(dimethylamino)phenoxy]-1H-tetrazol-1-yl}-5-[(1-naphthylcarbamoyl)amino]-L-iditol; ΔMass: -343.1569 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.69701375,25.90306001,1.193853694,0.255626046,0.053903658,0.26375688,Upregulated
Feature0322,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,0,0,3,0,0,0,1.615384615,0.230769231,-0.461538462,73.45384615,5,2,-0.142857143,0.058823529,-1,Lipid,22.43923506,26.78260452,1.193561387,0.255272769,0.097060133,0.283952518,Upregulated
Feature0256,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,2,0,0,1,0,0,0,1.444444444,0.222222222,-0.666666667,79.3,4,2,0.166666667,0.285714286,1,Phenol,23.97999624,28.53011204,1.18974631,0.25065398,2.54E-04,0.040009735,Upregulated
Feature0479,[Similar to: (±)5(6)-DiHET; ΔMass: -166.1745 Da],NA,172.07118,NA,[Similar to: (±)5(6)-DiHET; ΔMass: -166.1745 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.31368253,25.22154051,1.183349732,0.242876516,0.060362467,0.26375688,Upregulated
Feature0300,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,0,0,2,0,0,0,1.333333333,0.25,-0.333333333,69.8,6,3,0.142857143,0.294117647,1,Phenol,23.75210197,28.08703781,1.182507462,0.241849287,0.140529933,0.343517615,Upregulated
Feature0087,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid,6,11,2,0,0,1,0,0,0,1.833333333,0.333333333,-0.666666667,79.3,2,0,-0.333333333,0,-1,Protein,22.67936208,26.7206618,1.17819283,0.236575679,0.039260461,0.257062539,Upregulated
Feature0094,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,4,0,0,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.333333333,0,Phenol,23.72896922,27.92459091,1.176814326,0.234886714,0.091733482,0.272814166,Upregulated
Feature0022,RV0540000- ChemSpider,C5 H12 O4,136.07356,NA,RV0540000- ChemSpider,5,12,4,0,0,0,0,0,0,2.4,0.8,-0.8,83.1,0,-4,-4,-0.666666667,-4,Carbohydrate,22.26267102,26.12128538,1.173322166,0.230599197,0.060642248,0.26375688,Upregulated
Feature0549,NA,NA,684.19664,NA,Feature0549,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.28785498,26.12920611,1.172351764,0.229405515,0.218341002,0.424337637,Upregulated
Feature0143,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,3,0,0,1,0,0,0,1.1,0.3,-0.2,66,6,3,0.333333333,0.466666667,2,Phenol,23.59153652,27.64850046,1.171966923,0.228931852,0.002942431,0.107889127,Upregulated
Feature0127,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,3,0,0,1,0,0,0,1.857142857,0.428571429,-0.571428571,76.58571429,2,-1,-0.666666667,-0.111111111,-2,Protein,21.81241878,25.55283644,1.171481105,0.228333684,0.163672907,0.373527382,Upregulated
Feature0303,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,5,0,0,1,0,0,0,1.8,0.333333333,-0.933333333,86.9,3,-2,-0.333333333,-0.043478261,-3,Protein,21.35887974,24.98742,1.16988439,0.226365968,0.0124766,0.196060858,Upregulated
Feature0133,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide",C8 H11 N O4,185.06883,NA,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide",8,11,4,0,0,1,0,0,0,1.375,0.5,0,60.3,4,0,-0.333333333,0.2,-1,Phenol,22.68666667,26.48509048,1.167429789,0.223335786,0.009320993,0.181438821,Upregulated
Feature0060,NA,NA,159.08957,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Feature0060,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.41205948,26.16189002,1.167313073,0.223191543,0.042586689,0.26375688,Upregulated
Feature0407,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid],C18 H28 O3,310.21441,Metabolic pathways;Biosynthesis of secondary metabolites;Other,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid]-peak2,18,28,3,0,0,0,0,0,0,1.555555556,0.166666667,-1.222222222,95.13333333,5,2,0.133333333,0.212121212,2,Lipid,23.30087362,27.17895884,1.166435185,0.222106144,0.052428821,0.26375688,Upregulated
Feature0093,Penicillic acid isomer 1,C8 H10 O4,170.05554,NA,Penicillic acid isomer 1,8,10,4,0,0,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.333333333,0,Phenol,22.8985318,26.59003119,1.161211182,0.21563037,0.148432929,0.351888408,Upregulated
Feature0472,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,5,0,0,6,0,0,0,0.8,0.5,2,3.3,10,5,1,1,-1,Condensed HC,22.0172484,25.52060788,1.159118861,0.213028513,0.04850404,0.26375688,Upregulated
Feature0177,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,3,0,0,2,0,0,0,2,0.6,0.4,48.9,2,-1,#NAME?,-1,-3,Amino Sugar,24.08714729,27.9074562,1.158603626,0.212387085,0.087572035,0.272814166,Upregulated
Feature0211,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,3,0,0,1,0,0,0,2.142857143,0.428571429,-0.857142857,84.72857143,1,-2,-1,-0.333333333,-3,Protein,25.21164242,29.17866984,1.157349028,0.210824011,0.071268981,0.26375688,Upregulated
Feature0382,[Similar to: L-Glutamine],C5 H10 N2 O3,129.04259,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,[Similar to: L-Glutamine],5,10,3,0,0,2,0,0,0,2,0.6,0.4,48.9,2,-1,#NAME?,-1,-3,Amino Sugar,24.02629878,27.79754205,1.156963138,0.2103429,0.089992035,0.272814166,Upregulated
Feature0520,NA,C9 H11 N O3,181.07154,NA,Feature0520,9,11,3,0,0,1,0,0,0,1.222222222,0.333333333,-0.222222222,66.63333333,5,2,0.2,0.384615385,1,Phenol,22.37422449,25.86628071,1.156074961,0.209234947,0.045363776,0.26375688,Upregulated
Feature0218,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,2,0,0,1,0,0,0,1.9,0.2,-1.2,94.5,2,0,-0.142857143,0,-1,Lipid,23.73634398,27.40910026,1.154731339,0.207557231,0.054864512,0.26375688,Upregulated
Feature0334,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,2,0,0,1,0,0,0,2.142857143,0.285714286,-1.142857143,92.87142857,1,-1,-0.5,-0.2,-2,Lipid,20.10800198,23.18946154,1.153245437,0.205699584,0.249526369,0.447034212,Upregulated
Feature0103,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,4,0,0,0,0,0,0,1,0.4,-0.2,66,6,2,0.333333333,0.5,2,Phenol,22.77411257,26.21052106,1.150890995,0.202751197,0.16132569,0.369704706,Upregulated
Feature0245,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,3,0,0,6,0,0,0,4,1,4,-53.7,1,-2,1.333333333,1.444444444,-8,Other,24.56151175,28.19912294,1.148102088,0.199250931,0.104114059,0.28953887,Upregulated
Feature0406,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid],C18 H28 O3,292.20382,Metabolic pathways;Biosynthesis of secondary metabolites;Other,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid]-peak1,18,28,3,0,0,0,0,0,0,1.555555556,0.166666667,-1.222222222,95.13333333,5,2,0.133333333,0.212121212,2,Lipid,23.06817595,26.48369171,1.148061805,0.19920031,0.029786551,0.245104196,Upregulated
Feature0243,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,3,0,0,0,0,0,0,1.666666667,0.5,-0.666666667,79.3,2,-1,-0.333333333,0.111111111,-1,Protein,22.69637206,26.0056607,1.145806943,0.196363985,0.08756469,0.272814166,Upregulated
Feature0466,"[Similar to: [(1S,3R,13S,14S,17S,18R,19R,20S,21S,23R,24R,25S)-18,19,21-tris(acetyloxy)-24,25-dihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0Âa,Â?â°.0Âl,Â?Âl.0â·,ÂaÂ?]pentacosa-7(12),8,10-trien-20-yl]methyl acetate; ΔMass: -36.0466 Da]",NA,683.19594,NA,"[Similar to: [(1S,3R,13S,14S,17S,18R,19R,20S,21S,23R,24R,25S)-18,19,21-tris(acetyloxy)-24,25-dihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0Âa,Â?â°.0Âl,Â?Âl.0â·,ÂaÂ?]pentacosa-7(12),8,10-trien-20-yl]methyl acetate; ΔMass: -36.0466 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.49868288,26.91170946,1.145243314,0.19565414,0.252258739,0.450462034,Upregulated
Feature0347,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,12,0,0,2,0,0,0,1.92,0.48,-0.72,80.82,3,-9,-1,-0.294117647,-11,Protein,22.05316026,25.25488662,1.145182202,0.195577154,0.21481073,0.421587965,Upregulated
Feature0193,ile-his,C12 H20 N4 O3,268.15357,NA,ile-his,12,20,3,0,0,4,0,0,0,1.666666667,0.25,-0.166666667,65.05,5,2,-0.4,-0.076923077,-2,Lipid,21.96475745,25.10979024,1.14318541,0.193059409,0.152261474,0.359415496,Upregulated
Feature0100,NP-020521 mzCloud,C18 H32 O3,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,NP-020521 mzCloud,18,32,3,0,0,0,0,0,0,1.777777778,0.166666667,-1.444444444,101.4666667,3,0,0,0.090909091,0,Lipid,22.80710687,26.0065399,1.140282284,0.189391016,0.028428503,0.244490911,Upregulated
Feature0196,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,2,0,0,6,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,22.48697071,25.52075336,1.13491291,0.182581593,0.156870305,0.363689887,Upregulated
Feature0132,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide isomer",C8 H11 N O4,185.06882,NA,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide isomer",8,11,4,0,0,1,0,0,0,1.375,0.5,0,60.3,4,0,-0.333333333,0.2,-1,Phenol,22.85804994,25.86462151,1.131532286,0.17827775,0.004772859,0.140897433,Upregulated
Feature0473,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,3,0,0,0,0,3,0,1.727272727,0.272727273,-2.545454545,132.8454545,4,1,-0.4,-0.076923077,-2,Lipid,22.78972037,25.75443971,1.130090203,0.176437932,0.122355951,0.317432892,Upregulated
Feature0216,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,4,0,0,6,0,0,1,1.636363636,0.363636364,0.909090909,34.39090909,6,2,#NAME?,-1.5,-5,Protein,21.95647071,24.78971943,1.129039351,0.17509577,0.124211634,0.319235508,Upregulated
Feature0124,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,3,0,0,2,0,0,0,1.384615385,0.230769231,-0.461538462,73.45384615,6,3,0.125,0.263157895,1,Phenol,23.57736087,26.60057692,1.12822538,0.174055296,0.220937489,0.427871898,Upregulated
Feature0500,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0500,11,18,6,0,0,3,0,1,1,1.636363636,0.545454545,0,60.3,5,-1,#NAME?,-1,-6,Protein,23.65007578,26.67846896,1.128050041,0.173831069,0.123207423,0.318141234,Upregulated
Feature0405,"[Similar to: 9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one]",C11 H17 N O2,195.12596,NA,"[Similar to: 9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one]",11,17,2,0,0,1,0,0,0,1.545454545,0.181818182,-0.909090909,86.20909091,4,2,0.125,0.222222222,1,Lipid,22.37468088,25.21102534,1.126765806,0.172187688,0.461255332,0.63562334,Upregulated
Feature0459,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]",NA,172.07118,NA,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]-peak1",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.71689731,24.45195663,1.125941532,0.171131913,0.248077186,0.445890367,Upregulated
Feature0206,Ergocalciferol,C28 H44 O,378.32869,NA,Ergocalciferol,28,44,1,0,0,0,0,0,0,1.571428571,0.035714286,-1.5,103.05,7,6,0.222222222,0.236363636,6,Lipid,23.28176922,26.20253047,1.125452719,0.170505449,0.482351876,0.651826859,Upregulated
Feature0372,[Similar to: Maltitol; ΔMass: -198.0740 Da],NA,146.0579,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,[Similar to: Maltitol; ΔMass: -198.0740 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.39231692,26.27256102,1.123127782,0.167522078,0.102784219,0.28953887,Upregulated
Feature0142,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,3,0,0,0,0,0,0,1.666666667,0.5,-0.666666667,79.3,2,-1,-0.333333333,0.111111111,-1,Protein,22.77602258,25.56204298,1.122322517,0.166487316,0.155736616,0.362945503,Upregulated
Feature0096,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,4,0,0,1,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,23.20219787,25.98874035,1.120098212,0.163625236,0.180417816,0.38644127,Upregulated
Feature0065,NA,NA,204.06093,NA,Feature0065,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.37217546,27.25035065,1.118092666,0.161039762,0.093439828,0.274823025,Upregulated
Feature0389,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,6,0,0,0,0,1,0,2.75,1.5,-1,88.8,0,-6,2.333333333,#NAME?,-7,Other,22.4384605,25.07379627,1.117447263,0.160206746,0.217543719,0.424287395,Upregulated
Feature0320,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,0,0,0,1,0,0,0,1.761904762,0,-1.619047619,106.4428571,4,4,0.15,0.15,3,Lipid,25.09842722,28.01570357,1.116233432,0.158638762,0.07061534,0.26375688,Upregulated
Feature0266,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20383,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,3,0,0,0,0,0,0,1.555555556,0.166666667,-1.222222222,95.13333333,5,2,0.133333333,0.212121212,2,Lipid,22.80104585,25.44840846,1.116107069,0.158475433,0.144380683,0.346765832,Upregulated
Feature0337,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,3,0,0,0,0,0,0,1.333333333,0.5,-0.333333333,69.8,3,0,0,0.333333333,0,Phenol,23.1745278,25.85531514,1.115678186,0.157920946,0.090909016,0.272814166,Upregulated
Feature0486,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,0,0,0,1.7,0.15,-1.4,100.2,4,1,0.058823529,0.135135135,1,Lipid,23.83854778,26.58751985,1.115316255,0.157452854,0.178760283,0.38644127,Upregulated
Feature0053,NA,NA,318.21713,NA,Feature0053,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.74229645,25.35477485,1.114873113,0.156879523,0.064796813,0.26375688,Upregulated
Feature0241,Cafestol,C20 H28 O3,294.21942,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Cafestol,20,28,3,0,0,0,0,0,0,1.4,0.15,-1.1,91.65,7,4,0.235294118,0.297297297,4,Phenol,23.95834381,26.71013723,1.114857414,0.156859207,0.170509721,0.381941664,Upregulated
Feature0016,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,2,0,0,0,0,0,0,1.6,0.4,-0.8,83.1,2,0,0,0.25,0,Protein,22.98327555,25.60991198,1.114284686,0.156117871,0.073275462,0.26375688,Upregulated
Feature0002,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,0,0,1,0,0,0,1.8,0.2,-0.8,83.1,2,1,0,0.142857143,0,Lipid,22.46861171,25.03522805,1.114231194,0.156048611,0.070065799,0.26375688,Upregulated
Feature0398,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,6,0,0,1,0,0,0,2.428571429,0.857142857,-0.285714286,68.44285714,0,-6,#NAME?,-1.333333333,-7,Carbohydrate,22.01631504,24.4538641,1.110715579,0.151489433,0.070331628,0.26375688,Upregulated
Feature0264,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,2,0,0,1,0,0,0,1.545454545,0.181818182,-0.909090909,86.20909091,4,2,0.125,0.222222222,1,Lipid,20.96693498,23.27434487,1.110049938,0.150624581,0.567216254,0.715525091,Upregulated
Feature0032,NA,NA,194.05553,NA,Feature0032,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.06427709,24.48728546,1.109815897,0.150320373,0.126282997,0.32188544,Upregulated
Feature0021,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,2,0,0,0,0,0,0,1.333333333,0.333333333,-0.666666667,79.3,3,1,0.25,0.4,1,Phenol,23.16613553,25.7034784,1.109528103,0.149946209,0.177660155,0.386217727,Upregulated
Feature0261,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,4,0,0,5,0,0,0,1.3,0.4,1,31.8,7,3,-2,0,-2,Phenol,22.98423603,25.46451163,1.107912031,0.147843335,0.090860184,0.272814166,Upregulated
Feature0101,NP-019988 mzCloud,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988 mzCloud,10,10,4,0,0,0,0,0,0,1,0.4,-0.2,66,6,2,0.333333333,0.5,2,Phenol,22.36769939,24.76247712,1.107064106,0.146738765,0.223261268,0.428644321,Upregulated
Feature0175,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,6,0,0,0,0,0,0,2.333333333,1,-0.333333333,69.8,0,-6,#NAME?,-1,-6,Carbohydrate,26.20639935,28.9993689,1.10657586,0.146102357,0.101289801,0.288649691,Upregulated
Feature0240,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,4,0,0,0,0,0,0,0.888888889,0.444444444,0,60.3,6,2,0.4,0.571428571,2,Phenol,21.73565935,24.027242,1.105429636,0.144607196,0.041196285,0.260436283,Upregulated
Feature0514,NA,C35 H63 N O3,545.48106,NA,Feature0514,35,63,3,0,0,1,0,0,0,1.8,0.085714286,-1.542857143,104.2714286,5,2,0.032258065,0.076923077,1,Lipid,23.80382864,26.23426456,1.102102731,0.14025871,0.215393124,0.421587965,Upregulated
Feature0526,NA,C20 H32 N6 O3,404.25385,NA,Feature0526,20,32,3,0,0,6,0,0,0,1.6,0.15,-0.4,71.7,8,5,-0.090909091,0.04,-1,Lipid,24.18527557,26.59914902,1.099807564,0.137251115,0.237600412,0.440000763,Upregulated
Feature0385,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,4,0,0,1,0,0,1,2.5,0.666666667,-0.333333333,69.8,0,-4,#NAME?,-2,-6,Other,22.65488627,24.86202378,1.097424347,0.134121489,0.302264664,0.496255418,Upregulated
Feature0055,NA,NA,334.21216,NA,Feature0055,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.67562917,24.80525177,1.093916803,0.129503019,0.17942457,0.38644127,Upregulated
Feature0106,NP-014287 mzCloud,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287 mzCloud,18,32,3,0,0,0,0,0,0,1.777777778,0.166666667,-1.444444444,101.4666667,3,0,0,0.090909091,0,Lipid,23.2755504,25.45480927,1.093628672,0.129122972,0.091764765,0.272814166,Upregulated
Feature0015,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,8,0,0,2,0,0,0,1.818181818,0.727272727,0.181818182,55.11818182,3,-5,-7,-0.6,-7,Carbohydrate,23.29786698,25.46638413,1.093077926,0.128396255,0.154249523,0.361009521,Upregulated
Feature0113,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,4,0,0,0,0,0,0,1.7,0.2,-1.3,97.35,4,0,0,0.111111111,0,Lipid,24.64987498,26.92713791,1.09238436,0.127480564,0.19744387,0.396328937,Upregulated
Feature0463,[Similar to: 1-methyl-3-phenyl-1H-pyrazol-5-amine; ΔMass: 115.9834 Da],C9 H18 N5 P3,289.07872,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,[Similar to: 1-methyl-3-phenyl-1H-pyrazol-5-amine; ΔMass: 115.9834 Da],9,18,0,0,0,5,0,3,0,2,0,-2,117.3,5,5,-3,-3,-3,Lipid,23.20698756,25.32906665,1.091441385,0.126234654,0.077913664,0.26375688,Upregulated
Feature0437,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,402.16788,NA,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak3",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,20.35003347,22.20196348,1.091003782,0.125656103,0.396592927,0.599247554,Upregulated
Feature0084,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,3,0,0,4,0,0,0,1.454545455,0.272727273,0.181818182,55.11818182,6,3,-0.25,0.090909091,-1,Phenol,22.7509054,24.78820754,1.089548178,0.123729992,0.157462671,0.363689887,Upregulated
Feature0273,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,21.27036613,23.15798669,1.08874415,0.122664966,0.503105681,0.668377112,Upregulated
Feature0181,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,4,0,0,2,0,0,1,2,0.571428571,0.285714286,52.15714286,2,-2,#NAME?,-1.5,-5,Amino Sugar,23.39686222,25.46982062,1.088599846,0.122473738,0.194506169,0.395658864,Upregulated
Feature0064,NA,NA,376.259,NA,Feature0064,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.20910608,24.12748964,1.086378243,0.119526492,0.417140919,0.609486938,Upregulated
Feature0062,NA,NA,360.22765,NA,Feature0062,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.67761605,26.78989981,1.08559513,0.118486154,0.243795664,0.443998725,Upregulated
Feature0244,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,0,0,1,0,0,0,1.545454545,0.090909091,-1.090909091,91.39090909,4,3,0.222222222,0.263157895,2,Lipid,22.18430311,24.07044404,1.085021419,0.117723523,0.636265973,0.758553431,Upregulated
Feature0047,NA,NA,332.1964,NA,Feature0047,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.35510409,25.29357034,1.082999684,0.115032822,0.141919714,0.343762254,Upregulated
Feature0129,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,6,0,0,1,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,23.53523894,25.48080638,1.082666143,0.114588435,0.021242981,0.221205796,Upregulated
Feature0107,NP-014287,C18 H32 O3,318.21712,NA,NP-014287,18,32,3,0,0,0,0,0,0,1.777777778,0.166666667,-1.444444444,101.4666667,3,0,0,0.090909091,0,Lipid,23.02084407,24.89809627,1.081545759,0.113094705,0.106339731,0.28953887,Upregulated
Feature0516,NA,C35 H63 N O3,545.48105,NA,Feature0516,35,63,3,0,0,1,0,0,0,1.8,0.085714286,-1.542857143,104.2714286,5,2,0.032258065,0.076923077,1,Lipid,23.14925,25.02194991,1.080896785,0.112228767,0.470794195,0.644121411,Upregulated
Feature0239,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,4,0,0,0,0,0,0,1.2,0.4,-0.4,71.7,5,1,0.166666667,0.375,1,Phenol,21.57039248,23.16071345,1.07372703,0.102627268,0.244826255,0.444225198,Upregulated
Feature0031,NA,NA,366.11403,NA,Feature0031,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.91850015,24.59817704,1.073289128,0.102038769,0.103257996,0.28953887,Upregulated
Feature0543,NA,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Feature0543,5,14,6,0,0,1,0,1,0,2.8,1.2,-0.8,83.1,0,-6,2.666666667,#NAME?,-8,Other,23.62538536,25.3322275,1.072246108,0.100636079,0.121576742,0.316906199,Upregulated
Feature0035,NA,NA,233.07768,NA,Feature0035,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.80974047,25.50534427,1.071214711,0.099247679,0.049424604,0.26375688,Upregulated
Feature0192,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,0,0,2,0,0,0,1.2,0.4,0.8,37.5,4,2,0,0.5,0,Phenol,23.23462899,24.87462149,1.070583976,0.098397965,0.074050916,0.26375688,Upregulated
Feature0150,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,3,0,0,0,0,0,0,1.142857143,0.428571429,-0.285714286,68.44285714,4,1,0.25,0.454545455,1,Phenol,21.20800286,22.69854919,1.070282258,0.097991319,0.090578463,0.272814166,Upregulated
Feature0140,MFCD00025556 ChemSpider,C8 H14 N2 O5,218.09029,NA,MFCD00025556 ChemSpider,8,14,5,0,0,2,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.428571429,-4,Amino Sugar,24.20094695,25.89722674,1.070091464,0.097734113,0.005953314,0.155920123,Upregulated
Feature0329,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,2,0,0,3,0,0,0,1.666666667,0.222222222,-0.222222222,66.63333333,4,2,-0.25,0,-1,Lipid,24.74969696,26.47627089,1.069761417,0.097289076,0.205330714,0.408982087,Upregulated
Feature0275,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,4,0,0,1,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,23.79829056,25.4554969,1.06963552,0.09711928,0.092813404,0.274448238,Upregulated
Feature0343,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da],NA,202.04537,NA,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da]-peak1,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.34141445,27.10479219,1.069584819,0.097050894,0.232360859,0.434688682,Upregulated
Feature0451,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 291.8420 Da]",NA,701.85643,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 291.8420 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.35986364,24.98237653,1.069457293,0.096878871,0.003910533,0.134424564,Upregulated
Feature0163,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,3,0,0,2,0,0,0,1.466666667,0.2,-0.666666667,79.3,6,3,0.1,0.217391304,1,Phenol,23.54750928,25.17166405,1.068973527,0.096226126,0.034552069,0.246800495,Upregulated
Feature0092,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,0,0,0,2.4,1,-0.4,71.7,0,-5,#NAME?,-1,-5,Carbohydrate,24.05111175,25.70014924,1.068563878,0.095673154,0.346284562,0.545720656,Upregulated
Feature0325,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,3,0,0,0,0,0,0,1.666666667,0.166666667,-1.333333333,98.3,4,1,0.066666667,0.151515152,1,Lipid,23.06103063,24.63880855,1.068417494,0.095475503,0.067267273,0.26375688,Upregulated
Feature0074,NA,NA,566.21535,Biosynthesis of secondary metabolites;Other,Feature0074,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.97436267,22.40418936,1.068170209,0.095141554,0.441753354,0.627814845,Upregulated
Feature0154,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,0,0,1,0,0,0,1.363636364,0.090909091,-0.909090909,86.20909091,5,4,0.333333333,0.368421053,3,Unsaturated HC,22.41622154,23.92862481,1.067469143,0.094194368,0.691595125,0.792024249,Upregulated
Feature0410,[Similar to: 6-Aminocaproic acid],C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: 6-Aminocaproic acid]-peak1,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,22.70140081,24.23044234,1.067354501,0.094039419,0.23901308,0.441131524,Upregulated
Feature0260,Adenosine isomer,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine isomer,10,13,4,0,0,5,0,0,0,1.3,0.4,1,31.8,7,3,-2,0,-2,Phenol,27.64683633,29.46920289,1.065915917,0.092093638,0.062859106,0.26375688,Upregulated
Feature0452,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 223.8546 Da]",NA,633.86902,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 223.8546 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.46225317,25.00744697,1.065858713,0.092016211,0.004867366,0.140897433,Upregulated
Feature0429,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak7",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.02635994,22.37274518,1.064033206,0.089543175,0.448014503,0.631276681,Upregulated
Feature0425,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak3",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.22213106,22.57383857,1.063693298,0.089082228,0.369315153,0.572554982,Upregulated
Feature0297,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,164.04739,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other","3,4-Dihydroxyphenylpropionic acid-peak3",9,10,4,0,0,0,0,0,0,1.111111111,0.444444444,-0.222222222,66.63333333,5,1,0.2,0.428571429,1,Phenol,20.87822052,22.2033482,1.063469378,0.088778493,0.527117576,0.688633412,Upregulated
Feature0023,NA,NA,392.30162,NA,Feature0023,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.79350007,26.34229744,1.062467879,0.087419226,0.14250508,0.343762254,Upregulated
Feature0478,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,10,0,0,0,0,0,0,1.066666667,0.333333333,-0.4,71.7,15,5,0.25,0.4,5,Phenol,20.62872285,21.91550872,1.062378359,0.087297663,0.223653004,0.428644321,Upregulated
Feature0346,[Similar to: NP-022075; ΔMass: 142.0631 Da],C30 H32 O10,552.19968,NA,[Similar to: NP-022075; ΔMass: 142.0631 Da],30,32,10,0,0,0,0,0,0,1.066666667,0.333333333,-0.4,71.7,15,5,0.25,0.4,5,Phenol,20.95068008,22.25545613,1.062278458,0.087161993,0.113029133,0.301776813,Upregulated
Feature0236,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,4,0,0,1,0,0,1,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,26.92310079,28.59257594,1.062009022,0.086796022,0.086856493,0.272814166,Upregulated
Feature0057,NA,NA,246.07154,NA,Feature0057,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.79312047,24.20406932,1.0619024,0.086651173,0.140512637,0.343517615,Upregulated
Feature0043,NA,NA,320.23285,NA,Feature0043,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.56317584,23.94627114,1.061298786,0.085830874,0.00187221,0.085809611,Upregulated
Feature0403,[Similar to: AMIDINOPROLINE],C6 H11 N3 O2,157.08515,NA,[Similar to: AMIDINOPROLINE],6,11,2,0,0,3,0,0,0,1.833333333,0.333333333,0.333333333,50.8,3,1,-2,-0.5,-2,Protein,22.82352789,24.17091128,1.059034843,0.082750056,0.448336931,0.631276681,Upregulated
Feature0454,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 155.8671 Da]",NA,565.88152,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 155.8671 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.87404566,25.23221834,1.056889088,0.079823986,0.007155555,0.160598276,Upregulated
Feature0171,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,6,0,0,2,0,0,0,1.818181818,0.545454545,-0.181818182,65.48181818,3,-3,-1.666666667,-0.333333333,-5,Protein,23.91933738,25.27145636,1.056528279,0.079331383,0.498655862,0.665681369,Upregulated
Feature0197,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,5,0,0,3,0,0,0,1.583333333,0.416666667,0,60.3,5,0,-0.75,-0.076923077,-3,Protein,22.71096321,23.98100957,1.055922171,0.078503501,0.025902775,0.241466543,Upregulated
Feature0200,Glycyl-L-leucine isomer,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine isomer,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,21.31794844,22.50183204,1.055534593,0.077973861,0.371640234,0.572554982,Upregulated
Feature0191,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,2,0,0,1,0,0,0,0.9,0.2,-0.2,66,7,5,0.571428571,0.625,4,Phenol,23.72465904,25.02421987,1.054776797,0.07693774,0.225872441,0.43135362,Upregulated
Feature0212,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,4,0,0,2,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.166666667,-1,Phenol,28.1548738,29.69077859,1.054552004,0.076630242,0.054899995,0.26375688,Upregulated
Feature0202,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,6,0,0,0,0,1,0,3,2,-0.666666667,79.3,0,-6,1.75,4,-7,Other,24.43023716,25.75262909,1.054129312,0.076051856,0.315479806,0.511840393,Upregulated
Feature0134,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,0,0,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.638888889,0.666666667,11.5,Condensed HC,23.91229135,25.2038961,1.054014261,0.075894387,0.470775723,0.644121411,Upregulated
Feature0034,NA,NA,188.06609,NA,Feature0034,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.02147507,23.20364745,1.053682706,0.075440496,0.461045192,0.63562334,Upregulated
Feature0204,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,5,0,0,1,0,0,0,2.166666667,0.833333333,0,60.3,1,-4,#NAME?,-1,-5,Carbohydrate,23.51840031,24.7678209,1.053125237,0.07467701,0.300293554,0.494495374,Upregulated
Feature0296,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,164.04739,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other","3,4-Dihydroxyphenylpropionic acid-peak2",9,10,4,0,0,0,0,0,0,1.111111111,0.444444444,-0.222222222,66.63333333,5,1,0.2,0.428571429,1,Phenol,20.98294711,22.09140386,1.052826553,0.07426778,0.261745578,0.45993632,Upregulated
Feature0477,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,8,0,0,6,0,0,0,0.965517241,0.275862069,0.206896552,54.40344828,19,11,0.333333333,0.473684211,5,Phenol,20.52249603,21.55009938,1.050072045,0.070488315,0.668009195,0.77586207,Upregulated
Feature0450,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,13,0,0,0,0,3,0,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,24.18078023,25.35518146,1.048567549,0.068419803,0.012236541,0.196060858,Upregulated
Feature0547,NA,C8 H15 N O4,189.10013,NA,Feature0547,8,15,4,0,0,1,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,21.1474965,22.1608868,1.047920107,0.067528731,0.002873762,0.107889127,Upregulated
Feature0073,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0073,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.0680741,22.06863996,1.047492042,0.066939283,0.271522116,0.469649814,Upregulated
Feature0014,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,3,0,0,2,0,0,0,1.466666667,0.2,-0.666666667,79.3,6,3,0.1,0.217391304,1,Phenol,23.83807491,24.96905943,1.047444457,0.066873744,0.296900709,0.490376547,Upregulated
Feature0377,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak4,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,24.25906536,25.40732022,1.047333022,0.06672025,0.328056861,0.526452346,Upregulated
Feature0311,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,3,0,0,5,0,0,0,1.3,0.3,0.8,37.5,7,4,-0.5,0.142857143,-1,Phenol,22.05181874,23.09036032,1.047095507,0.066393039,0.419041037,0.609486938,Upregulated
Feature0378,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak5,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,24.26935375,25.40521901,1.046802452,0.065989208,0.332004737,0.527753194,Upregulated
Feature0458,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,4,0,0,0,0,2,1,0.363636364,0.363636364,-0.363636364,70.66363636,11,7,1,1,4,Condensed HC,24.04349268,25.15250249,1.046125154,0.065055461,0.007299922,0.160598276,Upregulated
Feature0453,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,9,0,0,6,0,3,1,0.833333333,1.5,3,-25.2,9,0,0.769230769,0.647058824,-10,Other,24.84942199,25.99161298,1.045964489,0.064833873,0.006310244,0.157756093,Upregulated
Feature0214,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,4,0,0,2,0,0,0,2,0.571428571,0,60.3,2,-2,-4,-0.666666667,-4,Amino Sugar,24.19923015,25.28390585,1.044822736,0.063258196,0.065290032,0.26375688,Upregulated
Feature0443,"[Similar to: 3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide]",C9 H17 N O6,235.10553,NA,"[Similar to: 3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide]",9,17,6,0,0,1,0,0,0,1.888888889,0.666666667,-0.222222222,66.63333333,2,-4,-2.5,-0.4,-5,Amino Sugar,23.17263378,24.20951211,1.044745812,0.063151976,0.210230688,0.415924024,Upregulated
Feature0149,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,7,0,0,1,0,0,0,1.363636364,0.636363636,0.181818182,55.11818182,5,-2,-1,0.076923077,-3,Phenol,27.58272277,28.81616532,1.04471794,0.063113487,0.048182904,0.26375688,Upregulated
Feature0005,α-Eleostearic acid,C18 H30 O2,278.22457,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,2,0,0,0,0,0,0,1.666666667,0.111111111,-1.444444444,101.4666667,4,2,0.125,0.176470588,2,Lipid,23.12805584,24.16185253,1.044698815,0.063087075,0.399057915,0.601320145,Upregulated
Feature0455,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,13,0,0,2,0,2,0,0.8,2.6,3.6,-42.3,6,-7,0.916666667,0.818181818,-11,Other,24.624197,25.72156454,1.044564602,0.06290172,0.008726286,0.177757685,Upregulated
Feature0040,NA,NA,276.08212,NA,Feature0040,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.01276082,25.08035813,1.044459582,0.062756665,0.230500965,0.434688682,Upregulated
Feature0063,NA,NA,145.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",Feature0063,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.99694893,24.01721137,1.044365122,0.062626182,0.608929534,0.750922072,Upregulated
Feature0155,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,4,0,0,0,0,0,0,1,0.4,-0.2,66,6,2,0.333333333,0.5,2,Phenol,23.96438984,25.02520466,1.044266298,0.06248966,0.620819272,0.756694593,Upregulated
Feature0165,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,0,0,1,0,0,0,2.214285714,0.071428571,-1.857142857,113.2285714,0,-1,-0.166666667,-0.12,-2,Lipid,20.76369792,21.67680294,1.043976031,0.062088589,0.07939098,0.26375688,Upregulated
Feature0457,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,6,0,0,2,0,1,1,1,2,4,-53.7,4,-2,0.857142857,0.75,-6,Other,26.88216008,28.04097914,1.043107364,0.060887658,0.002184615,0.092426005,Upregulated
Feature0045,NA,NA,283.1032,NA,Feature0045,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.69590278,22.62463098,1.042806617,0.060471642,0.079830078,0.26375688,Upregulated
Feature0433,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,2,0,0,6,0,0,0,1.894736842,0.105263158,-0.736842105,81.3,5,3,-0.272727273,-0.166666667,-3,Lipid,26.00570004,27.10650278,1.042329287,0.059811118,0.523659922,0.685745135,Upregulated
Feature0424,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak2",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,20.33586862,21.19595486,1.042294049,0.059762345,0.345339006,0.545720656,Upregulated
Feature0428,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak6",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,20.8843904,21.76381739,1.042109296,0.059506595,0.512135214,0.676840509,Upregulated
Feature0067,NA,NA,184.0348,NA,Feature0067,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.74114793,26.80275945,1.04124181,0.058305147,0.306644672,0.500458663,Upregulated
Feature0038,NA,NA,228.12221,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0038,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.2520784,25.228842,1.040275459,0.056965597,0.059879278,0.26375688,Upregulated
Feature0362,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,5,0,0,9,0,0,0,1.117647059,0.294117647,1.058823529,30.12352941,13,8,-0.333333333,0.272727273,-1,Phenol,21.50754377,22.35081026,1.03920794,0.055484359,0.506997115,0.671923887,Upregulated
Feature0280,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,4,0,0,0,0,0,0,2,0.8,-0.4,71.7,1,-3,-3,-0.333333333,-3,Carbohydrate,24.94175166,25.90821126,1.038748666,0.054846624,0.43790096,0.625572799,Upregulated
Feature0438,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,402.1679,NA,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak4",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,20.60151011,21.38772815,1.038163127,0.054033152,0.631160626,0.758553431,Upregulated
Feature0351,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,0,0,0,10,0,0,0,0.666666667,0,4.333333333,-63.2,10,10,0,0,0,Condensed HC,24.53019971,25.45655635,1.037763926,0.053478292,0.034080399,0.246800495,Upregulated
Feature0037,NA,NA,240.06096,NA,Feature0037,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.77271679,25.70732235,1.037727213,0.053427253,0.004208584,0.13616006,Upregulated
Feature0537,NA,C12 H12 N2 O S,232.07112,NA,Feature0537,12,12,1,0,0,2,0,0,1,1,0.083333333,-0.166666667,65.05,8,7,0.5,0.529411765,4,Unsaturated HC,26.15831662,27.08993672,1.035614681,0.050487323,1.30E-04,0.040009735,Upregulated
Feature0323,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,3,0,0,0,0,0,0,1.6,0.2,-1.2,94.5,4,1,0.083333333,0.185185185,1,Lipid,23.00270149,23.80833861,1.035023587,0.049663646,0.025847292,0.241466543,Upregulated
Feature0316,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,11,0,0,0,0,1,0,2.111111111,1.222222222,-0.222222222,66.63333333,1,-10,3.666666667,-2.2,-11,Carbohydrate,23.2079799,24.01613044,1.034822098,0.049382767,0.419600128,0.609486938,Upregulated
Feature0215,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,3,0,0,0,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.230769231,-3,Protein,26.76711091,27.69004916,1.034480309,0.048906184,2.91E-04,0.040009735,Upregulated
Feature0318,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,2,0,0,6,0,0,0,1.75,0.25,1,31.8,5,3,#NAME?,-2,-3,Lipid,25.81736211,26.69260894,1.033901482,0.048098721,8.99E-04,0.064342267,Upregulated
Feature0374,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17867,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak1,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,23.35395476,24.13098849,1.03327204,0.047220138,0.620051153,0.756694593,Upregulated
Feature0332,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,2,0,0,6,0,0,0,1.428571429,0.285714286,1.714285714,11.44285714,6,4,2,#NAME?,-2,Phenol,25.05815501,25.88738849,1.03309236,0.046969239,0.018440963,0.215273855,Upregulated
Feature0049,NA,NA,167.05586,NA,Feature0049,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.83335536,23.58718553,1.033014428,0.046860404,0.689475897,0.792024249,Upregulated
Feature0442,"[Similar to: 3,4-Methylenedioxy-N-propylamphetamine]",C13 H19 N O2,221.14159,NA,"[Similar to: 3,4-Methylenedioxy-N-propylamphetamine]",13,19,2,0,0,1,0,0,0,1.461538462,0.153846154,-0.923076923,86.60769231,5,3,0.2,0.272727273,2,Phenol,26.75431913,27.6340921,1.0328834,0.0466774,6.72E-04,0.061608057,Upregulated
Feature0456,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -252.0576 Da]",NA,157.9568,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -252.0576 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.88839815,25.6923927,1.032303989,0.045867873,0.024177053,0.241466543,Upregulated
Feature0028,NA,NA,300.14337,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0028,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.31108093,25.09240582,1.032138633,0.045636761,0.129740726,0.325061462,Upregulated
Feature0535,NA,C23 H40 N2 O3,370.31962,NA,Feature0535,23,40,3,0,0,2,0,0,0,1.739130435,0.130434783,-1.217391304,94.99565217,5,2,0,0.076923077,0,Lipid,26.39509601,27.23222486,1.031715318,0.045044941,6.20E-04,0.061608057,Upregulated
Feature0439,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid; ΔMass: -46.0418 Da]",C14 H21 N4 O5 P,356.1261,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid; ΔMass: -46.0418 Da]",14,21,5,0,0,4,0,1,0,1.5,0.357142857,-0.285714286,68.44285714,7,2,-0.75,-0.076923077,-3,Protein,20.36549162,21.00897948,1.031596971,0.044879443,0.519040481,0.682948001,Upregulated
Feature0180,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,2,0,0,3,0,0,1,1.666666667,0.222222222,0,60.3,4,2,-0.666666667,-0.25,-2,Lipid,23.15437833,23.88580595,1.031589171,0.044868534,0.19629091,0.395658864,Upregulated
Feature0533,NA,C2 H3 P S,89.96937,NA,Feature0533,2,3,0,0,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,25.78351902,26.5939229,1.031431081,0.044647426,0.008469105,0.177757685,Upregulated
Feature0489,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,0,0,0,2.285714286,1,-0.285714286,68.44285714,0,-7,#NAME?,-1,-7,Carbohydrate,23.46498723,24.20090126,1.031362217,0.0445511,0.559339226,0.709325102,Upregulated
Feature0112,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,3,0,0,0,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.384615385,1,Phenol,21.53940283,22.20867799,1.031072132,0.044145265,0.453770361,0.631832148,Upregulated
Feature0166,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,0,0,1,0,0,0,2.083333333,0.083333333,-1.666666667,107.8,1,0,-0.1,-0.047619048,-1,Lipid,25.18661511,25.95772093,1.030615699,0.043506473,0.02466349,0.241466543,Upregulated
Feature0317,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,3,0,0,1,0,0,0,1.1,0.3,-0.2,66,6,3,0.333333333,0.466666667,2,Phenol,24.34595648,25.08830287,1.030491568,0.0433327,0.040364124,0.258142651,Upregulated
Feature0495,NA,NA,581.85559,NA,Feature0495,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.25541139,24.9844507,1.03005677,0.042723851,0.036551871,0.249368809,Upregulated
Feature0265,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,0,0,5,0,0,0,1.3,0.5,1.2,26.1,7,2,#NAME?,-0.2,-3,Phenol,27.165499,27.98039467,1.029997449,0.042640764,0.007014388,0.160598276,Upregulated
Feature0088,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,2,0,0,0,0,0,0,1.666666667,0.111111111,-1.444444444,101.4666667,4,2,0.125,0.176470588,2,Lipid,24.0166993,24.72577813,1.029524408,0.041978034,0.60073333,0.746228884,Upregulated
Feature0183,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,6,0,0,1,0,1,0,2.5,0.75,-1.25,95.925,0,-6,#NAME?,-1.666666667,-8,Carbohydrate,29.0247478,29.87703811,1.029364262,0.041753601,0.029688968,0.245104196,Upregulated
Feature0024,NA,NA,257.08995,NA,Feature0024,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.08923172,23.76427697,1.029236367,0.041574339,0.185349741,0.387582678,Upregulated
Feature0011,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,0,0,2,0,0,0,1,0.5,1.5,17.55,4,2,NA,1,0,Phenol,24.75545982,25.46470737,1.028650146,0.040752391,0.258441352,0.45765358,Upregulated
Feature0497,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0497,9,8,17,0,0,0,0,2,2,0.888888889,1.888888889,2.222222222,-3.033333333,7,-10,1.166666667,1.571428571,-14,Other,24.37661986,25.06987787,1.028439464,0.040456877,0.013277263,0.197407885,Upregulated
Feature0168,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,3,0,0,1,0,0,0,1.222222222,0.333333333,-0.222222222,66.63333333,5,2,0.2,0.384615385,1,Phenol,26.93500308,27.69638982,1.028267557,0.040215705,0.419991908,0.609486938,Upregulated
Feature0026,NA,NA,409.15857,NA,Feature0026,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.77599249,24.44531785,1.028151311,0.040052599,0.028449851,0.244490911,Upregulated
Feature0070,NA,NA,313.07741,NA,Feature0070,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,27.14185166,27.90378034,1.028072096,0.039941441,0.145632536,0.348251716,Upregulated
Feature0501,NA,C10 H10 N2 O2,190.06944,NA,Feature0501,10,10,2,0,0,2,0,0,0,1,0.2,0,60.3,7,5,0.5,0.571428571,3,Phenol,24.20222841,24.87413059,1.027761996,0.039506211,0.074154629,0.26375688,Upregulated
Feature0230,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,10,0,0,0,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.227272727,0.37037037,5,Phenol,21.12477892,21.70785023,1.027601298,0.039280617,0.039766848,0.2573149,Upregulated
Feature0176,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,2,0,0,3,0,0,0,1.5,0.333333333,0.666666667,41.3,4,2,-1,0,-1,Protein,24.15609467,24.81648608,1.027338501,0.038911618,0.048561817,0.26375688,Upregulated
Feature0435,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,402.16791,NA,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak1",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,20.12249587,20.66338944,1.026880044,0.038267661,0.46227152,0.63562334,Upregulated
Feature0298,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,3,0,0,0,0,0,0,1.6,0.6,-0.4,71.7,2,-1,-0.5,0.142857143,-1,Amino Sugar,23.95208873,24.58874613,1.026580455,0.037846698,0.189936745,0.390296929,Upregulated
Feature0198,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,0,0,5,0,0,0,1.909090909,0.454545455,0.363636364,49.93636364,4,-1,-6,-1,-6,Protein,23.12461738,23.73849224,1.026546379,0.03779881,0.637723604,0.758553431,Upregulated
Feature0068,NA,NA,244.06955,Metabolic pathways;ABC transporters;Other,Feature0068,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.90709457,26.59481903,1.026545797,0.037797991,0.449011547,0.631276681,Upregulated
Feature0387,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,2,0,0,8,0,2,2,2.833333333,0.166666667,-1,88.8,1,-1,6.5,12,-13,Other,21.59226154,22.16077402,1.026329455,0.037493915,0.450360774,0.631276681,Upregulated
Feature0139,MFCD00063043 ChemSpider,C11 H14 N2 O3,222.10044,NA,MFCD00063043 ChemSpider,11,14,3,0,0,2,0,0,0,1.272727273,0.272727273,-0.181818182,65.48181818,6,3,0.166666667,0.333333333,1,Phenol,22.43563595,23.00752337,1.025490136,0.036313615,0.792170804,0.848147698,Upregulated
Feature0550,NA,C23 H38 O5,354.27704,NA,Feature0550,23,38,5,0,0,0,0,0,0,1.652173913,0.217391304,-1.217391304,94.99565217,5,0,0,0.12195122,0,Lipid,23.82733762,24.43186016,1.025370965,0.036145951,0.721674592,0.800244003,Upregulated
Feature0119,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,2,0,0,4,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,25.02642935,25.65976715,1.025306759,0.03605561,0.379403508,0.581286338,Upregulated
Feature0522,NA,C19 H20 N4 O2,318.1539,NA,Feature0522,19,20,2,0,0,4,0,0,0,1.052631579,0.105263158,-0.210526316,66.3,12,10,0.461538462,0.5,6,Unsaturated HC,24.94949331,25.58070783,1.025299693,0.036045668,0.231871978,0.434688682,Upregulated
Feature0530,NA,NA,101.96297,NA,Feature0530,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.21371957,25.84824568,1.025165906,0.035857405,0.330895255,0.527514174,Upregulated
Feature0029,NA,NA,318.14293,NA,Feature0029,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.22628807,24.83435834,1.025099605,0.035764098,0.189826602,0.390296929,Upregulated
Feature0358,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,8,0,0,6,0,0,0,0.888888889,0.296296296,0.37037037,49.74444444,19,11,0.384615385,0.529411765,5,Phenol,20.06238404,20.54204656,1.02390855,0.034086867,0.276597536,0.471394735,Upregulated
Feature0498,NA,C4 H N4 O7 P3,309.90566,NA,Feature0498,4,1,7,0,0,4,0,3,0,0.25,1.75,2.5,-10.95,8,1,0.6,0.384615385,-6,Other,24.31810096,24.89482613,1.023715881,0.033815369,0.018347041,0.215273855,Upregulated
Feature0041,NA,NA,247.09328,NA,Feature0041,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.13927336,25.73350145,1.023637441,0.033704822,0.052428368,0.26375688,Upregulated
Feature0312,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,3,0,0,5,0,0,0,1.3,0.3,0.8,37.5,7,4,-0.5,0.142857143,-1,Phenol,26.28490734,26.89831516,1.023336884,0.03328116,0.356478181,0.558584044,Upregulated
Feature0222,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,5,0,0,1,0,0,0,1.888888889,0.555555556,-0.444444444,72.96666667,2,-3,-1.333333333,-0.272727273,-4,Amino Sugar,24.04657,24.5851498,1.022397364,0.031956022,0.646128916,0.764238503,Upregulated
Feature0376,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak3,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,24.62045994,25.16471579,1.022105836,0.031544591,0.586253982,0.734486766,Upregulated
Feature0046,NA,NA,318.21715,NA,Feature0046,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.53463972,24.03042318,1.021066116,0.030076287,0.592327397,0.740409247,Upregulated
Feature0476,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,8,0,0,6,0,0,0,1,0.266666667,0.133333333,56.5,19,11,0.3125,0.45,5,Phenol,20.45379309,20.88001091,1.020838082,0.029754055,0.430020605,0.617523062,Upregulated
Feature0058,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0058,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.89319627,21.32849628,1.020834534,0.029749041,0.317363545,0.513382206,Upregulated
Feature0052,NA,NA,235.14196,NA,Feature0052,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.77773037,23.22710004,1.019728466,0.028185041,0.683328205,0.789559901,Upregulated
Feature0509,NA,C6 H5 O13 P3,377.89309,NA,Feature0509,6,5,13,0,0,0,0,3,0,0.833333333,2.166666667,1,31.8,6,-7,1,1,-10,Other,24.79811425,25.28552821,1.019655283,0.0280815,0.050044987,0.26375688,Upregulated
Feature0511,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0511,3,2,18,0,0,4,0,0,2,0.666666667,6,16.66666667,-414.7,5,-13,0.904761905,0.833333333,-19,Other,25.09343315,25.58480628,1.019581742,0.027977443,0.035598054,0.247834554,Upregulated
Feature0010,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,3,0,0,5,0,0,0,2.090909091,0.272727273,-0.181818182,65.48181818,3,0,-1.666666667,-0.777777778,-5,Lipid,23.61057218,24.07259885,1.019568635,0.027958897,0.572948871,0.721102698,Upregulated
Feature0448,[Similar to: 2-Iodoamphetamine; ΔMass: -45.0581 Da],NA,215.94331,NA,[Similar to: 2-Iodoamphetamine; ΔMass: -45.0581 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.99305381,25.48080782,1.019515583,0.027883827,0.362683156,0.566692431,Upregulated
Feature0302,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,10,0,0,0,0,0,0,1.034482759,0.344827586,-0.344827586,70.12758621,15,5,0.263157895,0.416666667,5,Phenol,21.03171156,21.43035418,1.01895436,0.027089432,0.26147246,0.45993632,Upregulated
Feature0144,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,3,0,0,0,0,0,0,1,0.3,-0.4,71.7,6,3,0.428571429,0.529411765,3,Phenol,21.0539324,21.44971377,1.018798454,0.026868675,0.421891342,0.610632206,Upregulated
Feature0185,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,2,0,0,1,0,0,0,2.2,0.4,-0.8,83.1,1,-1,-1,-0.333333333,-2,Protein,21.76515224,22.17371041,1.018771207,0.026830091,0.735456079,0.810352079,Upregulated
Feature0178,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,4,0,0,1,0,0,0,1.8,0.8,0.4,48.9,2,-2,#NAME?,-0.5,-3,Carbohydrate,28.47968272,29.0125539,1.018710573,0.026744224,0.107375431,0.290918656,Upregulated
Feature0114,NP-003459,C9 H14 O4,168.07869,Metabolic pathways;Other,NP-003459,9,14,4,0,0,0,0,0,0,1.555555556,0.444444444,-0.666666667,79.3,3,-1,-0.2,0.142857143,-1,Protein,22.37880824,22.79355817,1.018533156,0.026492944,0.236124994,0.438745766,Upregulated
Feature0449,[Similar to: 2-Iodoamphetamine; ΔMass: -27.0476 Da],NA,233.95388,NA,[Similar to: 2-Iodoamphetamine; ΔMass: -27.0476 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.4349976,25.89884558,1.018236604,0.026072834,0.371223911,0.572554982,Upregulated
Feature0427,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak5",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,20.8575162,21.23715949,1.01820175,0.02602345,0.784626175,0.846165482,Upregulated
Feature0110,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,0,0,2,0,0,0,1.636363636,0.181818182,-0.727272727,81.02727273,4,2,0,0.125,0,Lipid,26.17804982,26.64948103,1.018008645,0.025749814,0.079912778,0.26375688,Upregulated
Feature0019,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,3,0,0,2,0,0,0,2,0.272727273,-0.909090909,86.20909091,2,-1,-0.5,-0.2,-3,Lipid,24.07822777,24.50920078,1.017898867,0.02559423,0.713518055,0.800244003,Upregulated
Feature0233,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,0,0,2,0,0,0,1.142857143,0.142857143,-0.428571429,72.51428571,8,6,0.4,0.454545455,4,Phenol,26.64243601,27.10620764,1.017407254,0.024897285,0.060396453,0.26375688,Upregulated
Feature0152,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,2,0,0,1,0,0,1,2.2,0.4,-0.4,71.7,1,-1,-3,-1,-3,Protein,25.17597445,25.61118975,1.01728693,0.024726654,0.531994712,0.690319912,Upregulated
Feature0488,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,6,0,0,0,0,0,0,1,0.3,-0.4,71.7,11,5,0.357142857,0.470588235,5,Phenol,20.96731888,21.32776061,1.017190645,0.024590098,0.425648137,0.614452691,Upregulated
Feature0164,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,5,0,0,2,0,0,0,1.818181818,0.454545455,-0.363636364,70.66363636,3,-2,-1,-0.230769231,-4,Protein,23.90898622,24.31577977,1.017014253,0.024339898,0.323184154,0.521264764,Upregulated
Feature0423,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak1",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.32993546,21.69009125,1.016884992,0.024156522,0.668652039,0.77586207,Upregulated
Feature0388,[Similar to: Glycyl-L-leucine],C8 H16 N2 O3,188.11611,Metabolic pathways;Other,[Similar to: Glycyl-L-leucine],8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,23.86230225,24.26286317,1.016786348,0.024016566,0.380938636,0.581989583,Upregulated
Feature0174,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,0,0,2,0,0,0,2.333333333,0.333333333,-0.666666667,79.3,1,-1,-1.5,-0.666666667,-3,Other,25.30494596,25.70323724,1.015739661,0.02253068,0.328314827,0.526452346,Upregulated
Feature0269,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,0,0,0,1.142857143,0.571428571,0,60.3,4,0,0,0.4,0,Phenol,20.55589735,20.87760497,1.015650381,0.022403866,0.620905322,0.756694593,Upregulated
Feature0539,NA,C4 H2 O8 S2,241.91814,NA,Feature0539,4,2,8,0,0,0,0,0,2,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,26.53116413,26.93461578,1.015206707,0.021773506,0.02089612,0.221205796,Upregulated
Feature0310,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,3,0,0,2,0,0,0,1.555555556,0.333333333,-0.222222222,66.63333333,4,1,-0.25,0.090909091,-1,Protein,25.25294331,25.62060179,1.014559035,0.020852814,0.137405338,0.34041863,Upregulated
Feature0420,[Similar to: 4-Penten-1-amine],C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",[Similar to: 4-Penten-1-amine]-peak1,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,21.77136774,22.08148588,1.014244311,0.020405211,0.732773969,0.80928852,Upregulated
Feature0309,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,0,0,2,0,0,0,1.6,0.2,-0.6,77.4,4,2,0,0.142857143,0,Lipid,25.67390328,26.02767651,1.013779488,0.019743879,0.158039787,0.363689887,Upregulated
Feature0536,NA,C11 H20 N4 O3,256.15356,NA,Feature0536,11,20,3,0,0,4,0,0,0,1.818181818,0.272727273,-0.181818182,65.48181818,4,1,-0.75,-0.272727273,-3,Lipid,19.12157857,19.3680146,1.01288785,0.018474443,0.18531413,0.387582678,Upregulated
Feature0033,NA,NA,266.07009,Other,Feature0033,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.46895681,24.78121554,1.012761424,0.018294359,0.228351932,0.433081249,Upregulated
Feature0080,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,0,0,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,25.74297888,26.05898064,1.01227526,0.017601644,0.172629692,0.381941664,Upregulated
Feature0308,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,3,0,0,2,0,0,0,1.142857143,0.214285714,-0.285714286,68.44285714,8,5,0.333333333,0.428571429,3,Phenol,24.75663536,25.05394618,1.012009339,0.017222603,0.106052735,0.28953887,Upregulated
Feature0248,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,2,0,0,1,0,0,0,2.2,0.4,-0.8,83.1,1,-1,-1,-0.333333333,-2,Protein,30.0361831,30.39584994,1.011974452,0.017172869,0.63856407,0.758553431,Upregulated
Feature0252,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,0,0,0,2,0,0,0,0.833333333,0,-0.333333333,69.8,9,9,0.7,0.7,7,Unsaturated HC,19.59261782,19.82127361,1.011670508,0.016739493,0.625510636,0.758553431,Upregulated
Feature0051,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0051,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.01016603,21.25323043,1.011568895,0.016594581,0.522357668,0.685672356,Upregulated
Feature0271,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,3,0,0,0,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.692307692,3,Condensed HC,20.11972158,20.34768651,1.011330422,0.016254432,0.26772888,0.46895186,Upregulated
Feature0474,"[Similar to: (2S,3R,3aS,7aR)-2-(3,4-dimethoxyphenyl)-3a,7a-dimethoxy-3-methyl-5-(prop-2-en-1-yl)-2,3,3a,6,7,7a-hexahydro-1-benzofuran-6-one; ΔMass: 209.0692 Da]",C36 H41 N O3 P2,597.25775,NA,"[Similar to: (2S,3R,3aS,7aR)-2-(3,4-dimethoxyphenyl)-3a,7a-dimethoxy-3-methyl-5-(prop-2-en-1-yl)-2,3,3a,6,7,7a-hexahydro-1-benzofuran-6-one; ΔMass: 209.0692 Da]",36,41,3,0,0,1,0,2,0,1.138888889,0.083333333,-1.166666667,93.55,18,15,0.4,0.428571429,12,Unsaturated HC,20.59014563,20.81385879,1.01086506,0.015590425,0.258782297,0.45765358,Upregulated
Feature0082,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,8,0,0,1,0,0,0,1.5,0.8,0.4,48.9,4,-4,-5,-0.2,-5,Carbohydrate,25.00773628,25.27834423,1.010820969,0.015527498,0.702244261,0.794720872,Upregulated
Feature0059,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0059,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.27681489,21.50694374,1.010815944,0.015520326,0.691140507,0.792024249,Upregulated
Feature0289,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16794,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,20.51423415,20.73546462,1.010784242,0.015475078,0.29656148,0.490376547,Upregulated
Feature0315,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,6,0,0,0,0,0,0,0.947368421,0.315789474,-0.315789474,69.3,11,5,0.384615385,0.5,5,Phenol,20.26242193,20.47788266,1.010633513,0.015259926,0.451075883,0.631276681,Upregulated
Feature0534,NA,C19 H20 N4 O2,336.16458,NA,Feature0534,19,20,2,0,0,4,0,0,0,1.052631579,0.105263158,-0.210526316,66.3,12,10,0.461538462,0.5,6,Unsaturated HC,25.70687247,25.97437397,1.010405836,0.014934877,0.416062035,0.609486938,Upregulated
Feature0159,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,0,0,1,0,0,0,1.833333333,0.055555556,-1.555555556,104.6333333,3,2,0.0625,0.090909091,1,Lipid,23.31321125,23.5531191,1.010290639,0.014770386,0.618229902,0.756694593,Upregulated
Feature0279,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,7,0,0,1,0,0,0,1.666666667,0.777777778,0.222222222,53.96666667,3,-4,-5,-0.333333333,-5,Carbohydrate,25.39211526,25.6433634,1.009894731,0.014204917,0.419349626,0.609486938,Upregulated
Feature0158,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,0,0,3,0,0,0,2.083333333,0.25,-0.833333333,84.05,2,-1,-0.666666667,-0.333333333,-4,Lipid,24.44403322,24.67077262,1.009275859,0.013320551,0.875880035,0.902123631,Upregulated
Feature0234,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,0,0,2,0,0,0,1.636363636,0.181818182,-0.727272727,81.02727273,4,2,0,0.125,0,Lipid,27.08899634,27.33542183,1.009096885,0.013064697,0.391030314,0.594106831,Upregulated
Feature0044,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0044,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.88609091,21.07339062,1.008967676,0.012879956,0.648302957,0.764973685,Upregulated
Feature0436,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak2",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,21.17707356,21.36694037,1.008965677,0.012877098,0.408160749,0.609486938,Upregulated
Feature0281,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,2,0,0,0,0,0,0,1.2,0.2,-0.8,83.1,5,3,0.375,0.444444444,3,Phenol,22.54905828,22.7508711,1.008949944,0.012854602,0.809257177,0.857764025,Upregulated
Feature0257,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,2,0,0,3,0,0,0,1.833333333,0.333333333,0.333333333,50.8,3,1,-2,-0.5,-2,Protein,26.53757257,26.77296682,1.008870226,0.012740608,0.413660072,0.609486938,Upregulated
Feature0209,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,0,0,2,0,0,0,1.090909091,0.181818182,-0.181818182,65.48181818,7,5,0.428571429,0.5,3,Phenol,27.76935951,28.01560606,1.008867563,0.0127368,0.633275226,0.758553431,Upregulated
Feature0496,NA,C3 H5 N2 P S,131.99089,NA,Feature0496,3,5,0,0,0,2,0,1,1,1.666666667,0,-0.666666667,79.3,3,3,1,1,-1,Lipid,24.31271075,24.52140951,1.008583936,0.012331153,0.087493315,0.272814166,Upregulated
Feature0208,DL-Tryptophan isomer 1,C11 H12 N2 O2,187.06332,Microbial metabolism in diverse environments;Other,DL-Tryptophan isomer 1,11,12,2,0,0,2,0,0,0,1.090909091,0.181818182,-0.181818182,65.48181818,7,5,0.428571429,0.5,3,Phenol,27.64592921,27.88316076,1.008581066,0.012327048,0.637965444,0.758553431,Upregulated
Feature0375,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak2,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,23.40936798,23.60601886,1.008400521,0.012068768,0.8534745,0.885681084,Upregulated
Feature0356,[Similar to: NP-013538; ΔMass: 86.0004 Da],C15 H18 O11,374.08493,NA,[Similar to: NP-013538; ΔMass: 86.0004 Da],15,18,11,0,0,0,0,0,0,1.2,0.733333333,0.266666667,52.7,7,-4,-1,0.157894737,-4,Other,19.88974253,20.05230487,1.008173175,0.011743473,0.402738734,0.604349551,Upregulated
Feature0270,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,3,0,0,2,0,0,0,1.5,0.375,0,60.3,4,1,-0.333333333,0.111111111,-1,Protein,25.58184602,25.78335258,1.007876936,0.011319493,0.356146256,0.558584044,Upregulated
Feature0532,NA,C11 H22 N2 O3,230.16304,NA,Feature0532,11,22,3,0,0,2,0,0,0,2,0.272727273,-0.909090909,86.20909091,2,-1,-0.5,-0.2,-3,Lipid,24.93597946,25.12018552,1.00738716,0.010618248,0.843633879,0.88212668,Upregulated
Feature0540,NA,NA,103.99596,NA,Feature0540,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.93077662,27.11509742,1.006844244,0.009840519,0.081524854,0.26375688,Upregulated
Feature0493,NA,C H3 N O5,109.00137,NA,Feature0493,1,3,5,0,0,1,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,23.78196327,23.94439819,1.006830173,0.009820357,0.10513989,0.28953887,Upregulated
Feature0295,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,164.04738,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other","3,4-Dihydroxyphenylpropionic acid-peak1",9,10,4,0,0,0,0,0,0,1.111111111,0.444444444,-0.222222222,66.63333333,5,1,0.2,0.428571429,1,Phenol,20.88172068,21.02262418,1.006747696,0.00970217,0.850129229,0.883877271,Upregulated
Feature0518,NA,C30 H30 N6 O9,618.20799,NA,Feature0518,30,30,9,0,0,6,0,0,0,1,0.3,0.2,54.6,19,10,0.266666667,0.435897436,4,Phenol,20.25239207,20.38406627,1.006501662,0.009349554,0.533113275,0.690319912,Upregulated
Feature0118,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,1,0,0,3,0,0,0,2.333333333,0.111111111,-1.111111111,91.96666667,1,0,-0.6,-0.454545455,-3,Lipid,21.94080897,22.08176034,1.006424165,0.009238467,0.926256108,0.943395147,Upregulated
Feature0464,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,5,0,0,6,0,0,0,0.888888889,0.277777778,0.666666667,41.3,14,9,0.428571429,0.578947368,3,Phenol,19.88410878,20.01136174,1.006399732,0.009203443,0.513168168,0.676840509,Upregulated
Feature0207,DL-Tryptophan isomer 2,C11 H12 N2 O2,187.06332,Microbial metabolism in diverse environments;Other,DL-Tryptophan isomer 2,11,12,2,0,0,2,0,0,0,1.090909091,0.181818182,-0.181818182,65.48181818,7,5,0.428571429,0.5,3,Phenol,27.67632849,27.83730163,1.005816275,0.008366803,0.719423316,0.800244003,Upregulated
Feature0290,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21536,Biosynthesis of secondary metabolites;Other,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",31,34,10,0,0,0,0,0,0,1.096774194,0.322580645,-0.451612903,73.17096774,15,5,0.238095238,0.384615385,5,Phenol,20.84036863,20.95353159,1.005429988,0.007812625,0.767449238,0.829267349,Upregulated
Feature0503,NA,NA,100.00105,NA,Feature0503,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.56212271,24.69459234,1.005393248,0.007759906,0.276705168,0.471394735,Upregulated
Feature0187,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,28.54887154,28.69888089,1.005254476,0.007560759,0.596020033,0.743335642,Upregulated
Feature0545,NA,NA,85.98542,NA,Feature0545,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.76104114,26.90100164,1.00523001,0.007525647,0.117532555,0.309296198,Upregulated
Feature0117,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,1,0,0,2,0,0,0,1,0.166666667,0.333333333,50.8,5,4,0.666666667,0.714285714,2,Phenol,24.50898834,24.63598169,1.005181501,0.007456026,0.912187049,0.936012831,Upregulated
Feature0480,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,9,0,0,1,0,0,0,1.7,0.9,0.4,48.9,3,-6,#NAME?,-0.555555556,-7,Carbohydrate,25.89240833,26.02095983,1.004964834,0.007145019,0.874555439,0.902123631,Upregulated
Feature0173,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,2,0,0,1,0,0,0,1.222222222,0.222222222,-0.444444444,72.96666667,5,3,0.333333333,0.428571429,2,Phenol,29.27272717,29.4107929,1.004716531,0.00678852,0.71863664,0.800244003,Upregulated
Feature0499,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0499,9,9,6,0,0,2,0,3,4,1,0.666666667,0.222222222,53.96666667,8,2,1.166666667,1.333333333,-7,Other,24.4937528,24.6042308,1.004510456,0.006492581,0.56128114,0.709665809,Upregulated
Feature0169,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,3,0,0,1,0,0,0,2.25,0.75,0,60.3,1,-2,#NAME?,-1,-3,Carbohydrate,25.70575073,25.81963432,1.004430277,0.006377422,0.650337088,0.764973685,Upregulated
Feature0277,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,3,0,0,1,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,21.39656283,21.4884054,1.004292398,0.006179369,0.868843106,0.898240053,Upregulated
Feature0146,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,3,0,0,5,0,0,0,2.111111111,0.333333333,0.222222222,53.96666667,3,0,-5,-1.4,-5,Protein,23.29754618,23.3910737,1.004014479,0.005780075,0.918863163,0.939358252,Upregulated
Feature0170,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,3,0,0,1,0,0,0,2.333333333,1,0.666666667,41.3,1,-2,3,-3,-3,Carbohydrate,25.24959595,25.3474101,1.00387389,0.005578044,0.823406956,0.867432829,Upregulated
Feature0128,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,0,0,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.142857143,-1,Phenol,23.54714416,23.63490321,1.003726951,0.005366859,0.806608736,0.857764025,Upregulated
Feature0090,Phenacetin isomer 2,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin isomer 2,10,13,2,0,0,1,0,0,0,1.3,0.2,-0.6,77.4,5,3,0.285714286,0.375,2,Phenol,25.95635413,26.05277232,1.003714628,0.005349146,0.612857507,0.754075232,Upregulated
Feature0283,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,10,0,0,1,0,0,0,1.137931034,0.344827586,-0.344827586,70.12758621,14,4,0.166666667,0.347826087,3,Phenol,20.11606338,20.18235641,1.003295527,0.004746623,0.793056421,0.848147698,Upregulated
Feature0521,NA,C11 H11 N3 O S,233.0664,NA,Feature0521,11,11,1,0,0,3,0,0,1,1,0.090909091,0.181818182,55.11818182,8,7,0.5,0.538461538,3,Unsaturated HC,24.68266587,24.75578857,1.002962513,0.004267684,0.755328388,0.82426709,Upregulated
Feature0182,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,4,0,0,1,0,0,0,1.75,1,1,31.8,2,-2,3,-1,-3,Carbohydrate,26.06800004,26.14119253,1.002807752,0.004045054,0.720320943,0.800244003,Upregulated
Feature0341,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,6,0,0,0,0,1,0,2.6,1.2,-1.2,94.5,0,-6,3.5,-4,-7,Other,23.35172991,23.40510442,1.002285677,0.003293772,0.970716789,0.976040647,Upregulated
Feature0357,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,9,0,0,4,0,1,0,1.16,0.36,-0.16,64.86,14,5,0,0.290322581,0,Phenol,21.04213845,21.08971795,1.002261153,0.003258471,0.938755911,0.95054661,Upregulated
Feature0492,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0492,6,1,5,0,0,6,0,3,2,0.166666667,0.833333333,2.666666667,-15.7,11,6,0.5,0.333333333,-5,Other,24.30675988,24.34079957,1.00140042,0.002018966,0.842818323,0.88212668,Upregulated
Feature0336,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,7,0,0,0,0,0,0,1.142857143,0.333333333,-0.476190476,73.87142857,10,3,0.214285714,0.371428571,3,Phenol,20.94729169,20.97456133,1.001301822,0.001876911,0.930338317,0.944070248,Upregulated
Feature0156,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,4,0,0,2,0,0,0,2,0.4,-0.6,77.4,2,-2,-1,-0.333333333,-4,Protein,24.66193544,24.68248026,1.000833058,0.001201348,0.960817069,0.967856022,Upregulated
Feature0379,[Similar to: Leu-ala],C9 H18 N2 O3,202.1317,NA,[Similar to: Leu-ala]-peak1,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,24.51336627,24.52004824,1.000272585,3.93E-04,0.992097107,0.995071665,Upregulated
Feature0242,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,3,0,0,1,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.333333333,-0.185185185,-4,Lipid,23.02311762,23.01725796,0.999745488,-3.67E-04,0.998208863,0.998208863,Downregulated
Feature0123,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide,7,16,1,0,0,4,0,0,0,2.285714286,0.142857143,-0.285714286,68.44285714,2,1,-1.5,-1,-3,Lipid,21.57324036,21.55459623,0.999135776,-0.001247351,0.993262444,0.995071665,Downregulated
Feature0201,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,24.9292425,24.89727979,0.998717863,-0.00185092,0.914982622,0.937133039,Downregulated
Feature0294,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine",13,19,2,0,0,1,0,0,0,1.461538462,0.153846154,-0.923076923,86.60769231,5,3,0.2,0.272727273,2,Phenol,23.0304891,22.98000126,0.997807782,-0.003166173,0.922184596,0.94100469,Downregulated
Feature0510,NA,C18 H19 F3 N2,283.12969,NA,Feature0510,18,19,0,0,3,2,0,0,0,1.055555556,0,-0.722222222,80.88333333,10.5,10.5,0.53125,0.53125,8.5,Unsaturated HC,19.34304801,19.28448701,0.996972504,-0.004374378,0.630529346,0.758553431,Downregulated
Feature0255,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,3,0,0,5,0,0,0,1.533333333,0.2,-0.133333333,64.1,7,4,-0.142857143,0.058823529,-1,Lipid,24.06654195,23.96990914,0.995984766,-0.00580442,0.940177011,0.95054661,Downregulated
Feature0205,Furan,C4 H4 O,68.02622,Other,Furan,4,4,1,0,0,0,0,0,0,1,0.25,-0.5,74.55,3,2,0.666666667,0.714285714,2,Phenol,24.76601674,24.66138104,0.995775029,-0.006108258,0.927957772,0.943395147,Downregulated
Feature0421,[Similar to: 4-Penten-1-amine],C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",[Similar to: 4-Penten-1-amine]-peak2,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,25.31664377,25.2091105,0.995752467,-0.006140946,0.786677372,0.846717328,Downregulated
Feature0027,NA,NA,241.10379,NA,Feature0027,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,19.48018344,19.39556963,0.995656416,-0.006280116,0.849616482,0.883877271,Downregulated
Feature0125,N-alpha-Acetyllysine,C8 H16 N2 O3,188.1161,Metabolic pathways;Other,N-alpha-Acetyllysine,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,24.34079228,24.22743885,0.995343068,-0.006734226,0.712405111,0.800244003,Downregulated
Feature0505,NA,C18 H15 N3 O,289.11625,NA,Feature0505,18,15,1,0,0,3,0,0,0,0.833333333,0.055555556,-0.222222222,66.63333333,13,12,0.642857143,0.655172414,9,Unsaturated HC,22.41142275,22.3010152,0.995073604,-0.007124852,0.744156472,0.813689979,Downregulated
Feature0381,[Similar to: Leu-ala],C9 H18 N2 O3,202.1317,NA,[Similar to: Leu-ala]-peak3,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,24.68562106,24.55723001,0.994798954,-0.007523104,0.886627593,0.91148631,Downregulated
Feature0301,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,26.10281221,25.96554842,0.994741417,-0.007606548,0.539050945,0.694327915,Downregulated
Feature0314,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,5,0,0,2,0,0,0,1.8,0.5,-0.2,66,3,-2,-1.333333333,-0.272727273,-4,Protein,23.75623133,23.63047699,0.994706469,-0.007657236,0.641526337,0.760429925,Downregulated
Feature0391,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,5,0,0,2,1,0,1,1.75,1.25,2.75,-18.075,2.5,-2.5,1.375,2,-5.5,Carbohydrate,26.88988041,26.74709607,0.994690035,-0.007681072,0.276887938,0.471394735,Downregulated
Feature0099,NP-021733 mzCloud,C7 H13 N O2,143.09464,ABC transporters,NP-021733 mzCloud,7,13,2,0,0,1,0,0,0,1.857142857,0.285714286,-0.857142857,84.72857143,2,0,-0.25,0,-1,Lipid,20.88788877,20.77046726,0.994378489,-0.008133008,0.696726631,0.792024249,Downregulated
Feature0213,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,2,0,0,4,0,0,0,2.333333333,0.333333333,0.333333333,50.8,2,0,#NAME?,-3,-4,Other,26.92570125,26.76943027,0.994196215,-0.008397484,0.865139068,0.89609508,Downregulated
Feature0330,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,0,0,4,0,0,0,1.692307692,0.307692308,-0.153846154,64.68461538,5,1,-0.6,-0.142857143,-3,Protein,19.39341828,19.26819945,0.993543231,-0.009345352,0.663270607,0.772878886,Downregulated
Feature0513,NA,NA,257.89211,NA,Feature0513,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.06667223,24.9030996,0.993474498,-0.009445161,0.452758684,0.631832148,Downregulated
Feature0237,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,0,0,1,0,0,0,2.6,0.2,-1.6,105.9,0,-1,-0.666666667,-0.428571429,-2,Other,29.30711649,29.1080551,0.993207746,-0.009832583,0.626840511,0.758553431,Downregulated
Feature0366,[Similar to: muramic acid],C9 H17 N O7,251.10185,Metabolic pathways;ABC transporters;Other,[Similar to: muramic acid],9,17,7,0,0,1,0,0,0,1.888888889,0.777777778,0,60.3,2,-5,-6,-0.555555556,-6,Carbohydrate,23.91136578,23.74170924,0.992904774,-0.010272734,0.650923063,0.764973685,Downregulated
Feature0384,[Similar to: Isoleucine],C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: Isoleucine]-peak2,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,27.40881873,27.20949643,0.992727804,-0.010529895,0.658254515,0.768942077,Downregulated
Feature0426,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak4",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.18938926,21.03113842,0.9925316,-0.01081506,0.849819567,0.883877271,Downregulated
Feature0352,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,4,0,0,6,0,0,0,1.6,0.8,3.6,-42.3,5,1,1,1,-5,Carbohydrate,25.91184455,25.70201531,0.991902188,-0.011730231,0.715959386,0.800244003,Downregulated
Feature0007,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,2,0,0,1,0,0,0,2.2,0.4,-0.8,83.1,1,-1,-1,-0.333333333,-2,Protein,27.52778569,27.29315989,0.991476764,-0.012349132,0.558949386,0.709325102,Downregulated
Feature0504,NA,C12 H23 N O4,245.16269,NA,Feature0504,12,23,4,0,0,1,0,0,0,1.916666667,0.333333333,-1,88.8,2,-2,-0.428571429,-0.111111111,-3,Protein,20.49167375,20.29370361,0.990338996,-0.014005646,0.766570883,0.829267349,Downregulated
Feature0538,NA,C10 H19 N O8,281.11106,NA,Feature0538,10,19,8,0,0,1,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,25.25705295,25.00836394,0.990153681,-0.014275633,0.793116646,0.848147698,Downregulated
Feature0390,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,4,0,0,2,1,0,1,1.25,1,2.75,-18.075,3.5,-0.5,1.166666667,1.5,-3.5,Other,25.78652029,25.52848386,0.98999336,-0.014509246,0.06048562,0.26375688,Downregulated
Feature0291,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,2,0,0,0,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.333333333,2,Phenol,23.63215999,23.39154071,0.989818143,-0.014764609,0.824849763,0.867432829,Downregulated
Feature0491,NA,NA,121.9172,Microbial metabolism in diverse environments;Other,Feature0491,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.33621426,24.08740284,0.989776084,-0.014825912,0.336879364,0.533958646,Downregulated
Feature0008,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,3,0,0,2,0,0,0,2,0.272727273,-0.909090909,86.20909091,2,-1,-0.5,-0.2,-3,Lipid,23.74005925,23.48909622,0.989428711,-0.015332331,0.809417326,0.857764025,Downregulated
Feature0313,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,2,0,0,0,0,0,0,1.2,0.4,-0.4,71.7,3,1,0.333333333,0.5,1,Phenol,24.50203952,24.23886393,0.989259033,-0.015579761,0.740744294,0.813184439,Downregulated
Feature0115,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,0,0,1.6,0,-1.6,105.9,4,4,0.266666667,0.266666667,4,Lipid,21.7806916,21.5392382,0.988914337,-0.016082539,0.695817533,0.792024249,Downregulated
Feature0502,NA,C39 H74 N2 O6,666.55504,NA,Feature0502,39,74,6,0,0,2,0,0,0,1.897435897,0.153846154,-1.435897436,101.2230769,4,-2,-0.129032258,-0.029411765,-4,Lipid,21.25955187,21.02306886,0.988876388,-0.016137903,0.705936471,0.797258848,Downregulated
Feature0012,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,3,0,0,1,0,0,0,2.75,0.75,-0.5,74.55,0,-3,#NAME?,-1.666666667,-4,Other,24.34719235,24.07418838,0.988787045,-0.016268254,0.943190121,0.951843242,Downregulated
Feature0282,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,2,0,0,0,0,0,0,1,0.2,-0.6,77.4,6,4,0.5,0.555555556,4,Phenol,22.59696277,22.33322985,0.988328833,-0.016936965,0.757878345,0.825412059,Downregulated
Feature0167,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,2,0,0,1,0,0,0,2.333333333,0.666666667,0,60.3,1,-1,#NAME?,-1,-2,Other,26.5962157,26.28400761,0.988261184,-0.017035719,0.013366812,0.197407885,Downregulated
Feature0250,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,0,0,0,1,0,0,0,1.125,0,-0.75,81.675,5,5,0.571428571,0.571428571,4,Unsaturated HC,26.40551469,26.0950721,0.988243267,-0.017061875,0.195133328,0.395658864,Downregulated
Feature0319,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,0,0,0,1,0,0,0,1.761904762,0,-1.619047619,106.4428571,4,4,0.15,0.15,3,Lipid,22.68353823,22.4039605,0.987674862,-0.017891903,0.835451862,0.876905581,Downregulated
Feature0484,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09545,Metabolic pathways;ABC transporters;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",9,17,8,0,0,1,0,0,0,1.888888889,0.888888889,0.222222222,53.96666667,2,-6,#NAME?,-0.75,-7,Carbohydrate,25.12604884,24.76424625,0.985600498,-0.02092511,0.761377287,0.825951692,Downregulated
Feature0284,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,0,0,2,0,0,0,0.857142857,0.428571429,0.857142857,35.87142857,6,3,0.5,0.714285714,1,Phenol,22.20552956,21.88523597,0.985575954,-0.020961038,0.240673531,0.441472355,Downregulated
Feature0025,NA,NA,245.17401,NA,Feature0025,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.53504706,20.23698514,0.985485209,-0.021093876,0.822253117,0.867432829,Downregulated
Feature0288,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,3,0,0,2,0,0,0,2,0.3,-0.8,83.1,2,-1,-0.6,-0.230769231,-3,Lipid,24.55810157,24.20114266,0.985464719,-0.021123874,0.68713001,0.792024249,Downregulated
Feature0373,[Similar to: Maduramicin; ΔMass: -542.2962 Da],C18 H34 N2 O6,374.24339,NA,[Similar to: Maduramicin; ΔMass: -542.2962 Da],18,34,6,0,0,2,0,0,0,1.888888889,0.333333333,-0.888888889,85.63333333,3,-3,-0.5,-0.153846154,-5,Protein,22.33812587,22.01193799,0.985397706,-0.021221981,0.658494033,0.768942077,Downregulated
Feature0020,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,4,0,0,2,0,0,0,1.2,0.4,0.2,54.6,6,2,0,0.333333333,0,Phenol,19.71403759,19.41911116,0.985039775,-0.021746114,0.134689465,0.335200025,Downregulated
Feature0292,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,3,0,0,1,0,0,0,2.111111111,0.333333333,-1.111111111,91.96666667,1,-2,-0.6,-0.230769231,-3,Protein,22.21205437,21.87726816,0.984927724,-0.021910234,0.305198322,0.499580586,Downregulated
Feature0331,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,5,0,0,1,0,0,0,2.5,0.833333333,-0.333333333,69.8,0,-5,#NAME?,-1.4,-6,Carbohydrate,21.11327509,20.78420797,0.984414207,-0.022662615,0.701285634,0.794720872,Downregulated
Feature0327,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,5,0,0,0,0,0,1,2.333333333,0.833333333,-0.333333333,69.8,0,-5,#NAME?,-1.4,-6,Carbohydrate,22.16358273,21.81647414,0.984338787,-0.022773151,0.621865375,0.756694593,Downregulated
Feature0148,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,4,0,0,0,0,0,0,1.272727273,0.363636364,-0.545454545,75.84545455,5,1,0.142857143,0.333333333,1,Phenol,20.00708134,19.67531435,0.983417522,-0.024124035,0.55030478,0.705518949,Downregulated
Feature0161,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,3,0,0,0,0,0,0,1.6,0.6,-0.4,71.7,2,-1,-0.5,0.142857143,-1,Amino Sugar,24.81355766,24.39270776,0.983039518,-0.024678681,0.696981339,0.792024249,Downregulated
Feature0444,[Similar to: 3-hydroxy-3-methylpentanedioic acid],C6 H10 O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Other,[Similar to: 3-hydroxy-3-methylpentanedioic acid],6,10,5,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,2,-3,-3,-0.142857143,-3,Carbohydrate,28.52788131,28.04304786,0.983004926,-0.024729448,0.490152125,0.659128775,Downregulated
Feature0483,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,7,0,0,1,0,0,0,1.4,0.466666667,-0.266666667,67.9,6,-1,-0.285714286,0.142857143,-2,Phenol,25.42927281,24.99690746,0.982997337,-0.024740586,0.820368793,0.867432829,Downregulated
Feature0131,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,6,0,0,1,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,24.71086283,24.26854326,0.982100197,-0.026057874,0.709657816,0.79981926,Downregulated
Feature0153,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,0,0,0,1,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,25.6072643,25.14536721,0.981962263,-0.026260512,0.130024585,0.325061462,Downregulated
Feature0360,[Similar to: Ne-Acetyllysine],C8 H16 N2 O3,188.11612,Metabolic pathways;Other,[Similar to: Ne-Acetyllysine]-peak2,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,24.44740593,24.00515377,0.981910058,-0.026337214,0.607207745,0.750481482,Downregulated
Feature0141,MFCD00025555 ChemSpider,C9 H18 N2 O3,202.1317,NA,MFCD00025555 ChemSpider,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,25.65358532,25.15319121,0.980494184,-0.028419022,0.546676295,0.702504585,Downregulated
Feature0111,NP-008521,C14 H18 N2 O2,268.1171,NA,NP-008521,14,18,2,0,0,2,0,0,0,1.285714286,0.142857143,-0.571428571,76.58571429,7,5,0.3,0.363636364,3,Phenol,20.29157444,19.88519065,0.979972782,-0.029186415,0.205978251,0.408982087,Downregulated
Feature0422,[Similar to: 4-Penten-1-amine],C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",[Similar to: 4-Penten-1-amine]-peak3,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,23.54322218,23.06534706,0.979702221,-0.029584784,0.553335106,0.707754205,Downregulated
Feature0383,[Similar to: Isoleucine],C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: Isoleucine]-peak1,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,23.07828691,22.59753501,0.979168649,-0.030370729,0.736683708,0.810352079,Downregulated
Feature0263,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,4,0,0,1,0,0,0,1.888888889,0.444444444,-0.666666667,79.3,2,-2,-0.75,-0.166666667,-3,Protein,21.61089134,21.1594561,0.979110753,-0.030456034,0.679034427,0.786250389,Downregulated
Feature0542,NA,C23 H38 O5,376.259,NA,Feature0542,23,38,5,0,0,0,0,0,0,1.652173913,0.217391304,-1.217391304,94.99565217,5,0,0,0.12195122,0,Lipid,22.66566197,22.16292334,0.977819371,-0.032360108,0.742215615,0.813184439,Downregulated
Feature0083,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,2,0,0,1,0,0,0,1.8,0.4,-0.4,71.7,2,0,-0.5,0,-1,Protein,28.24043898,27.60708446,0.977572781,-0.032723979,0.196390673,0.395658864,Downregulated
Feature0307,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,3,0,0,2,0,0,0,1.333333333,0.25,-0.333333333,69.8,6,3,0.142857143,0.294117647,1,Phenol,25.02484898,24.46319617,0.977556196,-0.032748455,0.475180154,0.645306382,Downregulated
Feature0226,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,7,0,0,0,0,0,0,2,1.166666667,0.333333333,50.8,1,-6,6,-1,-6,Carbohydrate,24.44917994,23.88916607,0.977094779,-0.033429584,0.555233588,0.708534741,Downregulated
Feature0188,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,0,0,0,1,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,23.98086914,23.42748384,0.976923885,-0.033681933,0.800211177,0.852938271,Downregulated
Feature0475,"[Similar to: (2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-({[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol; ΔMass: -117.0465 Da]",C6 H20 N9 O5 P,329.13228,NA,"[Similar to: (2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-({[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol; ΔMass: -117.0465 Da]",6,20,5,0,0,9,0,1,0,3.333333333,0.833333333,2,3.3,2,-3,1.444444444,1.615384615,-13,Other,23.90447405,23.32110426,0.97559579,-0.035644562,0.601053446,0.746228884,Downregulated
Feature0333,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,7,0,0,1,0,0,0,1.9,0.7,-0.2,66,2,-5,-3,-0.454545455,-6,Amino Sugar,26.57857969,25.92663344,0.97547099,-0.035829127,0.75948881,0.825531315,Downregulated
Feature0440,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,10,0,0,1,0,2,0,1.681818182,0.454545455,-1.090909091,91.39090909,6,-4,-0.777777778,-0.142857143,-7,Protein,22.52136593,21.96673683,0.975373203,-0.035973758,0.794174662,0.848147698,Downregulated
Feature0393,[Similar to: D-Raffinose],C18 H32 O16,526.15108,NA,[Similar to: D-Raffinose]-peak2,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,25.3352457,24.68643422,0.974390954,-0.037427356,0.48373419,0.652092658,Downregulated
Feature0223,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,4,0,0,2,0,0,0,2,0.444444444,-0.444444444,72.96666667,2,-2,-1.333333333,-0.4,-4,Protein,25.04019226,24.39237753,0.974129004,-0.037815254,0.294772143,0.490332352,Downregulated
Feature0324,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,4,0,0,3,0,0,0,1.9,0.4,-0.2,66,3,-1,-1.333333333,-0.4,-4,Protein,24.35262895,23.70299453,0.973323849,-0.03900819,0.55972199,0.709325102,Downregulated
Feature0321,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,6,0,0,1,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,24.18351965,23.52861272,0.972919288,-0.039607969,0.719043808,0.800244003,Downregulated
Feature0238,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,0,0,0,1,0,0,0,2.157894737,0,-2,117.3,0,0,-0.055555556,-0.055555556,-1,Lipid,21.50487004,20.91759148,0.972690904,-0.039946668,0.246498111,0.44450479,Downregulated
Feature0179,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13722,NA,L-gamma-Glutamyl-L-leucine,11,20,5,0,0,2,0,0,0,1.818181818,0.454545455,-0.363636364,70.66363636,3,-2,-1,-0.230769231,-4,Protein,24.3853234,23.69548226,0.971710806,-0.041401082,0.180573466,0.38644127,Downregulated
Feature0364,[Similar to: N-Methyl-Nâ€²-piperazinoacetohydrazide],C7 H16 N4 O,172.13244,NA,[Similar to: N-Methyl-Nâ€²-piperazinoacetohydrazide],7,16,1,0,0,4,0,0,0,2.285714286,0.142857143,-0.285714286,68.44285714,2,1,-1.5,-1,-3,Lipid,21.09336223,20.4640717,0.970166419,-0.043695852,0.693529672,0.792024249,Downregulated
Feature0137,MFCD09839908 ChemSpider,C11 H16 N2 O3,224.11608,NA,MFCD09839908 ChemSpider,11,16,3,0,0,2,0,0,0,1.454545455,0.272727273,-0.363636364,70.66363636,5,2,0,0.2,0,Phenol,23.64788297,22.93440588,0.969829135,-0.044197501,0.181649469,0.387237241,Downregulated
Feature0054,NA,NA,264.07224,NA,Feature0054,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.13630089,25.33014103,0.969155548,-0.04519986,0.076145418,0.26375688,Downregulated
Feature0121,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,0,0,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,22.03331662,21.35125075,0.969043886,-0.045366092,0.576392576,0.723780632,Downregulated
Feature0350,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,0,0,0,10,0,0,0,0.666666667,0,4.333333333,-63.2,10,10,0,0,0,Condensed HC,24.98245712,24.20096213,0.968718249,-0.045850975,0.190181049,0.390296929,Downregulated
Feature0254,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,3,0,0,5,0,0,0,2.090909091,0.272727273,-0.181818182,65.48181818,3,0,-1.666666667,-0.777777778,-5,Lipid,22.9153536,22.19511145,0.96856945,-0.046072595,0.214092465,0.421587965,Downregulated
Feature0130,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,7,0,0,1,0,0,0,1.875,0.875,0.25,53.175,2,-5,#NAME?,-0.714285714,-6,Carbohydrate,25.32222323,24.51341416,0.968059318,-0.046832643,0.533426777,0.690319912,Downregulated
Feature0160,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,6,0,0,1,0,0,0,1.7,0.6,-0.2,66,3,-3,-1.333333333,-0.166666667,-4,Amino Sugar,24.69308834,23.89411286,0.967643761,-0.04745208,0.654040288,0.766998206,Downregulated
Feature0001,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,2,0,0,1,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,26.92889968,26.04059324,0.967012895,-0.048392967,0.329770196,0.52724886,Downregulated
Feature0009,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,3,0,0,4,0,0,0,1.636363636,0.272727273,0,60.3,5,2,-0.5,-0.090909091,-2,Lipid,23.78976048,22.97081135,0.965575562,-0.050538932,0.058952223,0.26375688,Downregulated
Feature0494,NA,C11 H23 N3 O3,245.17392,NA,Feature0494,11,23,3,0,0,3,0,0,0,2.090909091,0.272727273,-0.727272727,81.02727273,2,-1,-0.8,-0.384615385,-4,Lipid,23.41981386,22.5786531,0.964083371,-0.052770183,0.228329025,0.433081249,Downregulated
Feature0085,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,0,0,0,1,0,0,0,1.782608696,0,-1.652173913,107.3869565,4,4,0.136363636,0.136363636,3,Lipid,22.08283508,21.28296631,0.96377871,-0.053226163,0.428817814,0.617407847,Downregulated
Feature0061,NA,NA,175.08448,NA,Feature0061,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.33746546,24.40213211,0.963084968,-0.05426501,0.295090925,0.490332352,Downregulated
Feature0278,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,4,0,0,1,0,0,2,2.3,0.4,-0.8,83.1,0,-4,-2.333333333,-1,-7,Protein,23.6588059,22.77084599,0.962468101,-0.055189368,0.629221217,0.758553431,Downregulated
Feature0306,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,5,0,0,1,0,0,0,1.1,0.5,0.2,54.6,6,1,0,0.384615385,0,Phenol,19.92029582,19.13484035,0.96057009,-0.058037208,0.15318636,0.360053411,Downregulated
Feature0116,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,2,0,0,1,0,0,0,0.833333333,0.333333333,0.333333333,50.8,5,3,0.666666667,0.75,2,Phenol,24.71597785,23.73664377,0.960376478,-0.058328025,0.167935414,0.380100732,Downregulated
Feature0287,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,3,0,0,2,0,0,0,2,0.3,-0.8,83.1,2,-1,-0.6,-0.230769231,-3,Lipid,22.67866003,21.74704169,0.958920927,-0.060516241,0.635919779,0.758553431,Downregulated
Feature0524,NA,C10 H7 Cl N4,218.04022,NA,Feature0524,11,7,0,0,0,4,1,0,0,0.636363636,0,0.454545455,47.34545455,10.5,10.5,0.928571429,0.928571429,6.5,Condensed HC,23.96552604,22.94763462,0.957526849,-0.062615155,0.370286486,0.572554982,Downregulated
Feature0228,D-(+)-Glucose isomer,C6 H12 O6,197.08998,NA,D-(+)-Glucose isomer,6,12,6,0,0,0,0,0,0,2,1,0,60.3,1,-5,#NAME?,-0.666666667,-5,Carbohydrate,25.11463314,24.01909371,0.956378442,-0.064346485,0.165852961,0.376938549,Downregulated
Feature0097,octadec-9-ynoic acid,C18 H32 O2,262.22971,NA,octadec-9-ynoic acid,18,32,2,0,0,0,0,0,0,1.777777778,0.111111111,-1.555555556,104.6333333,3,1,0.0625,0.117647059,1,Lipid,23.15235003,22.13686733,0.956139109,-0.064707563,0.47341762,0.645306382,Downregulated
Feature0077,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,0,0,2,0,0,0,1.6,0.4,0.4,48.9,3,1,-1,0,-1,Protein,24.46124322,23.38376548,0.955951636,-0.064990464,0.291006272,0.486484649,Downregulated
Feature0224,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,9,0,0,0,0,1,0,2.166666667,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,25.4621111,24.30771636,0.954662253,-0.066937678,0.030927579,0.246524182,Downregulated
Feature0017,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,0,0,2,0,0,0,1.2,0.4,0.8,37.5,4,2,0,0.5,0,Phenol,24.65685202,23.51335202,0.953623439,-0.068508399,0.051187763,0.26375688,Downregulated
Feature0079,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,3,0,0,1,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.272727273,0,Phenol,24.0506332,22.90069069,0.952186602,-0.070683766,0.533429023,0.690319912,Downregulated
Feature0135,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,6,0,0,1,0,0,0,1.666666667,0.666666667,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,25.86932893,24.62552457,0.951919729,-0.071088173,0.480878601,0.651436529,Downregulated
Feature0136,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,7,0,0,1,0,0,0,1.888888889,0.777777778,0,60.3,2,-5,-6,-0.555555556,-6,Carbohydrate,25.97992339,24.71948634,0.951484189,-0.071748412,0.495412179,0.662960337,Downregulated
Feature0186,Kanosamine,C6 H13 N O5,161.06907,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Kanosamine,6,13,5,0,0,1,0,0,0,2.166666667,0.833333333,0,60.3,1,-4,#NAME?,-1,-5,Carbohydrate,23.70683632,22.54334631,0.950921751,-0.072601464,0.537719987,0.69423942,Downregulated
Feature0229,D-(+)-Glucose,C6 H12 O6,197.08999,NA,D-(+)-Glucose,6,12,6,0,0,0,0,0,0,2,1,0,60.3,1,-5,#NAME?,-0.666666667,-5,Carbohydrate,29.32430192,27.86070336,0.950089227,-0.073865085,0.193365561,0.395357094,Downregulated
Feature0004,α-Lactose,C12 H22 O11,359.14285,NA,α-Lactose,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,25.09423973,23.83534842,0.949833455,-0.074253523,0.241783959,0.441797931,Downregulated
Feature0072,NA,NA,277.11616,NA,Feature0072,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,27.18118586,25.81063251,0.949577132,-0.074642903,0.231782792,0.434688682,Downregulated
Feature0507,NA,C10 H17 N7 O8,363.11421,NA,Feature0507,10,17,8,0,0,7,0,0,0,1.7,0.8,2,3.3,6,-2,1.8,5,-9,Carbohydrate,24.38780985,23.14446471,0.949017761,-0.075493007,0.44592209,0.631276681,Downregulated
Feature0293,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,3,0,0,0,0,0,0,1.2,0.3,-0.6,77.4,5,2,0.285714286,0.411764706,2,Phenol,22.66254046,21.48867711,0.948202482,-0.076732926,0.728046253,0.805684988,Downregulated
Feature0363,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,9,0,0,5,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.230769231,-6,Phenol,23.01235585,21.78591062,0.946704925,-0.079013267,0.034425425,0.246800495,Downregulated
Feature0523,NA,C9 H9 N O4,179.07955,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0523,9,9,4,0,0,1,0,0,0,1,0.444444444,0.222222222,53.96666667,6,2,0.25,0.5,1,Phenol,24.70236475,23.37630365,0.946318455,-0.079602333,0.414258829,0.609486938,Downregulated
Feature0232,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,5,0,0,3,0,0,0,1.444444444,0.555555556,0.666666667,41.3,5,0,-3,-0.142857143,-3,Phenol,24.28646492,22.92900011,0.944106118,-0.082979066,0.379421446,0.581286338,Downregulated
Feature0353,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,7,0,0,1,0,0,0,2.5,1.166666667,0.333333333,50.8,0,-7,4,-3,-8,Carbohydrate,24.03608028,22.68461729,0.94377357,-0.083487325,0.175267337,0.384051933,Downregulated
Feature0359,[Similar to: Ne-Acetyllysine],C8 H16 N2 O3,188.11612,Metabolic pathways;Other,[Similar to: Ne-Acetyllysine]-peak1,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,20.48578165,19.32421641,0.943298954,-0.084213027,0.08004145,0.26375688,Downregulated
Feature0162,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,3,0,0,2,0,0,0,1.818181818,0.272727273,-0.727272727,81.02727273,3,0,-0.333333333,-0.066666667,-2,Lipid,25.65792775,24.19469918,0.942971678,-0.084713655,0.474379105,0.645306382,Downregulated
Feature0225,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,6,0,0,0,0,0,0,1.666666667,1,0.333333333,50.8,2,-4,#NAME?,-0.333333333,-4,Carbohydrate,24.06907334,22.68495863,0.942494059,-0.085444571,0.146651514,0.349170273,Downregulated
Feature0517,NA,C11 H21 N O8 S,327.09887,Other,Feature0517,11,21,8,0,0,1,0,0,1,1.909090909,0.727272727,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,24.09808371,22.70408085,0.942152958,-0.085966795,0.409134066,0.609486938,Downregulated
Feature0006,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,3,0,0,2,0,0,0,1.8,0.3,-0.6,77.4,3,0,-0.4,-0.076923077,-2,Lipid,25.60103529,24.11840228,0.94208699,-0.086067814,0.313328423,0.509853943,Downregulated
Feature0267,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,2,0,0,4,0,0,0,1.272727273,0.181818182,0.181818182,55.11818182,7,5,0.2,0.333333333,1,Phenol,23.8587248,22.47277498,0.941910147,-0.086338653,0.492307041,0.660411884,Downregulated
Feature0184,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,3,0,0,2,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.666666667,-0.111111111,-2,Protein,24.43330608,22.99160355,0.940994373,-0.087741998,0.403265973,0.604349551,Downregulated
Feature0274,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,10,0,0,1,0,0,0,1.916666667,0.833333333,0,60.3,2,-8,-9,-0.666666667,-9,Carbohydrate,25.90434882,24.37180987,0.940838546,-0.087980927,0.269898864,0.469649814,Downregulated
Feature0408,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]",C11 H14 N4 O2,234.11165,NA,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]-peak1",11,14,2,0,0,4,0,0,0,1.272727273,0.181818182,0.181818182,55.11818182,7,5,0.2,0.333333333,1,Phenol,23.22070082,21.84506662,0.940758283,-0.088104009,0.602885699,0.74681787,Downregulated
Feature0258,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,23.1388462,21.76294486,0.940537168,-0.088443138,0.282571416,0.476730917,Downregulated
Feature0399,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,4,0,0,1,0,1,0,2.8,0.8,-1.6,105.9,0,-4,6,-4,-6,Other,22.46020456,21.08169043,0.938624151,-0.091380514,0.410129351,0.609486938,Downregulated
Feature0344,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da],NA,202.04538,NA,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da]-peak2,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,27.7897972,26.05930142,0.937729097,-0.092756897,0.141537466,0.343762254,Downregulated
Feature0380,[Similar to: Leu-ala],C9 H18 N2 O3,202.1317,NA,[Similar to: Leu-ala]-peak2,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,22.4941025,21.09217321,0.937675696,-0.092839056,0.441519909,0.627814845,Downregulated
Feature0048,NA,NA,454.10871,NA,Feature0048,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,27.01766763,25.29644285,0.936292622,-0.094968606,0.182870717,0.387582678,Downregulated
Feature0482,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,4,0,0,6,0,0,0,1.5,1,5,-82.2,5,1,0.833333333,0.75,-5,Carbohydrate,26.6196659,24.86336974,0.934022607,-0.098470626,0.365114556,0.568875371,Downregulated
Feature0395,[Similar to: D-(+)-Maltose],C12 H22 O11,364.09814,NA,[Similar to: D-(+)-Maltose]-peak1,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,26.55446543,24.79035231,0.933566235,-0.099175712,0.173808157,0.382377946,Downregulated
Feature0525,NA,C18 H23 N5,309.19516,NA,Feature0525,18,23,0,0,0,5,0,0,0,1.277777778,0,-0.444444444,72.96666667,10,10,0.384615385,0.384615385,5,Unsaturated HC,24.68197313,23.00448095,0.932035734,-0.101542826,0.272396892,0.469649814,Downregulated
Feature0147,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,7,0,0,1,0,0,0,1.909090909,0.636363636,-0.363636364,70.66363636,2,-5,-2,-0.384615385,-6,Amino Sugar,25.34711268,23.59272791,0.930785616,-0.103479178,0.395433788,0.599142104,Downregulated
Feature0095,Palmitic Acid,C16 H32 O2,273.2668,NA,Palmitic Acid,16,32,2,0,0,0,0,0,0,2,0.125,-1.75,110.175,1,-1,-0.071428571,0,-1,Lipid,23.81274248,22.13574699,0.92957571,-0.105355724,0.382815113,0.583236322,Downregulated
Feature0268,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,2,0,0,1,0,0,0,2.214285714,0.142857143,-1.714285714,109.1571429,0,-2,-0.272727273,-0.166666667,-3,Lipid,24.01899042,22.32666016,0.92954199,-0.105408057,0.272375901,0.469649814,Downregulated
Feature0276,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,4,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,3,-1,-0.5,0.25,-1,Other,24.34617905,22.62730636,0.929398667,-0.105630519,0.284189188,0.477994047,Downregulated
Feature0151,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,3,0,0,1,0,0,1,2.2,0.6,0,60.3,1,-2,#NAME?,-1.666666667,-4,Amino Sugar,25.05931575,23.26336167,0.928331879,-0.107287434,0.126413191,0.32188544,Downregulated
Feature0253,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,3,0,0,2,0,0,0,2,0.75,1,31.8,2,-1,3,-3,-3,Carbohydrate,24.3320888,22.5665287,0.927439024,-0.108675662,0.172184215,0.381941664,Downregulated
Feature0018,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,2,0,0,0,0,0,0,1,0.5,0,60.3,3,1,0.5,0.666666667,1,Phenol,25.78277892,23.85229892,0.925125216,-0.112279447,0.138837177,0.34242353,Downregulated
Feature0172,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,3,0,0,1,0,0,0,1.4,0.6,0.4,48.9,3,0,-1,0.2,-1,Phenol,26.30816624,24.328436,0.924748452,-0.112867115,0.185939622,0.387582678,Downregulated
Feature0305,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,5,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,2,-3,-3,-0.142857143,-3,Carbohydrate,27.82959284,25.68522814,0.922946602,-0.115680914,0.128557278,0.325061462,Downregulated
Feature0411,[Similar to: 6-Aminocaproic acid],C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: 6-Aminocaproic acid]-peak2,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,21.41572101,19.74203138,0.921847617,-0.117399805,0.020080019,0.220880212,Downregulated
Feature0235,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,7,0,0,0,0,0,0,1.333333333,1.166666667,1,31.8,3,-4,4,-0.2,-4,Other,28.84129557,26.58623267,0.921811318,-0.117456614,0.277694353,0.471394735,Downregulated
Feature0328,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,7,0,0,1,0,0,0,1.916666667,0.583333333,-0.5,74.55,2,-5,-1.5,-0.333333333,-6,Amino Sugar,26.41869362,24.35269185,0.921797731,-0.117477878,0.258406369,0.45765358,Downregulated
Feature0259,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,0,0,0,4,0,0,0,2.8,0,-0.4,71.7,1,1,-3,-3,-3,Other,25.65366286,23.64300055,0.921622798,-0.11775169,0.456690405,0.633577156,Downregulated
Feature0231,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,11,0,0,4,0,2,0,1.857142857,0.785714286,-0.142857143,64.37142857,5,-6,4,-2.6,-12,Carbohydrate,23.55355145,21.67303257,0.920159859,-0.120043574,0.435291603,0.623464536,Downregulated
Feature0203,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,4,0,0,0,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,24.06045522,22.13674047,0.920046619,-0.120221131,0.075019873,0.26375688,Downregulated
Feature0412,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,6,0,0,10,0,0,0,1.272727273,0.545454545,2.545454545,-12.24545455,10,4,1.2,1.5,-6,Phenol,23.88956259,21.96187285,0.919308287,-0.12137935,0.271000772,0.469649814,Downregulated
Feature0441,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,12,0,0,1,0,0,0,2.083333333,1,0.166666667,55.55,1,-11,12,-1.2,-12,Carbohydrate,24.37302255,22.37511881,0.918028068,-0.123389831,0.088492067,0.272814166,Downregulated
Feature0400,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,7,0,0,1,0,0,0,1.833333333,1.166666667,1,31.8,2,-5,3,-1.666666667,-6,Carbohydrate,27.95396699,25.55882791,0.914318455,-0.129231355,0.279619129,0.473201603,Downregulated
Feature0462,"[Similar to: 1,2,3-Tris({4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl}methyl) 2-hydroxypropane-1,2,3-tricarboxylate; ΔMass: -782.3022 Da]",NA,214.00891,NA,"[Similar to: 1,2,3-Tris({4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl}methyl) 2-hydroxypropane-1,2,3-tricarboxylate; ΔMass: -782.3022 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,27.53677933,25.06532374,0.910248924,-0.135666965,0.276794423,0.471394735,Downregulated
Feature0527,NA,C18 H11 F3 N2,312.08214,NA,Feature0527,18,11,0,0,3,2,0,0,0,0.611111111,0,-0.277777778,68.21666667,14.5,14.5,0.78125,0.78125,12.5,Condensed HC,22.39660955,20.36896583,0.909466488,-0.136907616,0.033308027,0.246800495,Downregulated
Feature0071,NA,NA,230.07661,NA,Feature0071,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.10763619,23.62306161,0.904833415,-0.144275887,0.457327511,0.633577156,Downregulated
Feature0512,NA,C18 H34 N2 O12,470.2113,NA,Feature0512,18,34,12,0,0,2,0,0,0,1.888888889,0.666666667,-0.222222222,66.63333333,3,-9,-2.75,-0.5,-11,Amino Sugar,24.59978145,22.15273759,0.900525789,-0.151160503,0.240803103,0.441472355,Downregulated
Feature0246,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,10,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,3,-7,-3.5,-0.285714286,-7,Carbohydrate,25.59777129,23.04542263,0.9002902,-0.15153798,0.063659409,0.26375688,Downregulated
Feature0109,NP-013538 mzCloud,C12 H16 O8,288.08457,NA,NP-013538 mzCloud-peak2,12,16,8,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,5,-3,-0.75,0.125,-3,Other,23.02325046,20.70932314,0.899496063,-0.152811128,0.05409143,0.26375688,Downregulated
Feature0190,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,5,0,0,4,0,0,0,1.2,0.5,1,31.8,7,2,-2,0.142857143,-2,Phenol,25.99649124,23.36712857,0.898857017,-0.153836453,0.033783233,0.246800495,Downregulated
Feature0397,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,6,0,0,1,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,24.89133501,22.36307748,0.898428207,-0.154524872,0.503003848,0.668377112,Downregulated
Feature0485,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,4,0,0,0,0,0,0,0.8,0.8,0.8,37.5,4,0,0,0.666666667,0,Condensed HC,24.39184131,21.89322942,0.897563622,-0.155913891,0.289410777,0.485292461,Downregulated
Feature0089,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,3,0,0,0,0,0,0,1,0.5,0,60.3,4,1,0.333333333,0.555555556,1,Phenol,24.52766395,22.00671273,0.897220085,-0.156466178,0.080622813,0.26375688,Downregulated
Feature0220,D-Raffinose isomer 1,C18 H32 O16,521.19564,NA,D-Raffinose isomer 1,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,27.56602762,24.70738197,0.896298238,-0.157949235,0.03850528,0.255467577,Downregulated
Feature0529,NA,C18 H25 N5 O10,471.15896,NA,Feature0529,18,25,10,0,0,5,0,0,0,1.388888889,0.555555556,0.555555556,44.46666667,9,-1,-2,-0.125,-6,Phenol,24.90499341,22.29557893,0.895225249,-0.159677368,0.047293071,0.26375688,Downregulated
Feature0392,[Similar to: D-Raffinose],C18 H32 O16,526.15105,NA,[Similar to: D-Raffinose]-peak1,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,26.14762291,23.39564566,0.894752297,-0.160439753,0.053851508,0.26375688,Downregulated
Feature0086,Pipecolic acid isomer,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid isomer,6,11,2,0,0,1,0,0,0,1.833333333,0.333333333,-0.666666667,79.3,2,0,-0.333333333,0,-1,Protein,25.40635333,22.70371245,0.893623424,-0.162261093,0.026370943,0.241733646,Downregulated
Feature0467,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,14,0,0,1,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,24.52504988,21.91162191,0.893438424,-0.162559794,0.019178943,0.215273855,Downregulated
Feature0394,[Similar to: D-Raffinose],C18 H32 O16,526.15103,NA,[Similar to: D-Raffinose]-peak3,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,24.14799656,21.55957728,0.892810185,-0.163574609,0.128875709,0.325061462,Downregulated
Feature0126,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,2,0,0,3,0,0,0,1.727272727,0.181818182,-0.545454545,75.84545455,4,2,-0.166666667,0,-1,Lipid,25.32544451,22.60886375,0.892733146,-0.163699102,0.009638358,0.181438821,Downregulated
Feature0285,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,2,0,0,3,0,0,0,2.2,0.4,0.4,48.9,2,0,#NAME?,-2,-3,Protein,24.78644562,22.10895386,0.891977583,-0.164920642,0.036725225,0.249368809,Downregulated
Feature0434,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,14,0,0,1,0,2,0,1.678571429,0.5,-0.928571429,86.76428571,7,-7,-0.909090909,-0.166666667,-10,Protein,24.35738633,21.7230049,0.891844659,-0.165135651,0.20287003,0.40574006,Downregulated
Feature0419,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,4,0,0,8,0,1,0,1.833333333,0.666666667,2.666666667,-15.7,6,2,1,1,-7,Amino Sugar,26.01953718,23.20411858,0.891795977,-0.165214403,0.021677719,0.221205796,Downregulated
Feature0432,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,17,0,0,5,0,0,0,1.64,0.68,0.32,51.18,8,-9,-4.666666667,-0.47826087,-14,Amino Sugar,23.8337812,21.24663635,0.891450508,-0.165773392,0.028249916,0.244490911,Downregulated
Feature0249,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,15,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,4,-11,-3.666666667,-0.333333333,-11,Carbohydrate,24.9974977,22.25773822,0.89039865,-0.167476689,0.080927994,0.26375688,Downregulated
Feature0217,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,2,0,0,0,0,0,0,1,0.333333333,-0.333333333,69.8,4,2,0.5,0.6,2,Phenol,23.32690392,20.76768125,0.890288798,-0.167654691,0.104358587,0.28953887,Downregulated
Feature0342,[Similar to: Tetrolic Acid]?,C4 H4 O2,84.02115,Metabolic pathways;Other,[Similar to: Tetrolic Acid]?,4,4,2,0,0,0,0,0,0,1,0.5,0,60.3,3,1,0.5,0.666666667,1,Phenol,24.69614917,21.97601615,0.889855985,-0.168356227,0.060411595,0.26375688,Downregulated
Feature0369,[Similar to: methyl N-acetylneuraminate],C12 H21 N O9,323.12167,NA,[Similar to: methyl N-acetylneuraminate]-peak1,12,21,9,0,0,1,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.384615385,-7,Carbohydrate,24.90366198,22.12117074,0.888269796,-0.17093016,0.245535382,0.444225198,Downregulated
Feature0081,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,0,0,5,0,0,0,1.307692308,0.384615385,0.615384615,42.76153846,8,3,-0.666666667,0.090909091,-2,Phenol,24.28311383,21.5600206,0.887860624,-0.171594874,0.07783988,0.26375688,Downregulated
Feature0286,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,1,0,0,3,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,25.12694927,22.27738178,0.886593177,-0.173655835,0.017586422,0.215273855,Downregulated
Feature0221,D-Raffinose,C18 H32 O16,526.15103,NA,D-Raffinose,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,25.84876942,22.88281154,0.885257289,-0.175831278,0.075927275,0.26375688,Downregulated
Feature0227,D-(+)-Maltose,C12 H22 O11,364.09813,NA,D-(+)-Maltose,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,27.94804022,24.73909656,0.885181801,-0.175954305,0.099721169,0.285900687,Downregulated
Feature0345,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,2,0,0,5,0,0,0,1.727272727,0.181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,24.37359347,21.54249193,0.883845542,-0.178133824,0.16906011,0.381078117,Downregulated
Feature0417,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]-peak1",6,8,4,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,3,-1,-0.5,0.25,-1,Other,24.98335634,22.07137069,0.883442976,-0.178791079,0.099776877,0.285900687,Downregulated
Feature0396,[Similar to: D-(+)-Maltose],C12 H22 O11,364.09813,NA,[Similar to: D-(+)-Maltose]-peak2,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,25.78253879,22.76628734,0.883011852,-0.179495292,0.081054013,0.26375688,Downregulated
Feature0102,NP-019811 mzCloud,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811 mzCloud,6,7,2,0,0,1,0,0,0,1.166666667,0.333333333,0,60.3,4,2,0.333333333,0.5,1,Phenol,25.41185045,22.38956847,0.881068009,-0.182674711,0.109556689,0.293932579,Downregulated
Feature0078,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,3,0,0,0,0,0,0,1,0.5,0,60.3,4,1,0.333333333,0.555555556,1,Phenol,24.41518297,21.43219321,0.877822347,-0.187999098,0.075334662,0.26375688,Downregulated
Feature0098,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,3,0,0,1,0,0,0,2.166666667,0.5,-0.666666667,79.3,1,-2,-1.5,-0.428571429,-3,Protein,25.46847406,22.35549901,0.877771435,-0.188082774,0.189545801,0.390296929,Downregulated
Feature0354,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,17,0,0,5,0,0,0,1.64,0.68,0.32,51.18,8,-9,-4.666666667,-0.47826087,-14,Amino Sugar,24.71245978,21.68770692,0.877602113,-0.188361096,0.109355129,0.293932579,Downregulated
Feature0199,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,1,0,0,5,0,0,0,1,0.2,2.4,-8.1,6,5,0,-1,0,Phenol,25.08130445,21.93774291,0.87466515,-0.193197283,0.171680658,0.381941664,Downregulated
Feature0409,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]",C11 H14 N4 O2,234.11166,NA,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]-peak2",11,14,2,0,0,4,0,0,0,1.272727273,0.181818182,0.181818182,55.11818182,7,5,0.2,0.333333333,1,Phenol,23.01839298,20.09692381,0.873081098,-0.195812427,0.177205243,0.386217727,Downregulated
Feature0340,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,5,0,0,6,0,0,0,1.428571429,0.714285714,2.571428571,-12.98571429,6,1,1.25,1.666666667,-5,Other,28.85810611,25.17005255,0.87220043,-0.197268393,0.233811851,0.435920401,Downregulated
Feature0076,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,2,0,0,0,0,0,0,0.8,0.4,0,60.3,4,2,0.666666667,0.75,2,Condensed HC,24.89596206,21.68361672,0.870969223,-0.199306356,0.032780467,0.246800495,Downregulated
Feature0528,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0528,14,26,10,0,0,6,0,0,0,1.857142857,0.714285714,0.857142857,35.87142857,5,-5,5.5,-2,-11,Carbohydrate,24.37747009,21.21850705,0.870414648,-0.200225259,0.415965611,0.609486938,Downregulated
Feature0003,α-Lactose isomer,C12 H22 O11,359.14284,NA,α-Lactose isomer,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,30.1365558,26.13918081,0.867357935,-0.205300618,0.001343462,0.067173118,Downregulated
Feature0013,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,2,0,0,1,0,0,0,1,0.285714286,0,60.3,5,3,0.5,0.6,2,Phenol,23.83156512,20.65134146,0.866554142,-0.206638204,0.089355448,0.272814166,Downregulated
Feature0418,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]-peak2",6,8,4,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,3,-1,-0.5,0.25,-1,Other,25.54531192,22.09359087,0.864878493,-0.209430633,0.025070332,0.241466543,Downregulated
Feature0104,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,4,0,0,2,0,0,0,1.636363636,0.363636364,-0.363636364,70.66363636,4,0,-0.4,0,-2,Protein,25.64771793,22.16679776,0.864279536,-0.210430092,0.115377204,0.306557789,Downregulated
Feature0326,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,9,0,0,2,0,1,0,1.444444444,1,0.666666667,41.3,5,-4,2.333333333,-1.666666667,-7,Other,26.15599775,22.40945053,0.856761449,-0.223034529,0.044347717,0.26375688,Downregulated
Feature0145,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate,12,21,9,0,0,1,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.384615385,-7,Carbohydrate,24.28787027,20.80433732,0.856573141,-0.223351655,0.118233605,0.309659441,Downregulated
Feature0413,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,24.91598603,21.33989106,0.856473873,-0.223518857,0.078054823,0.26375688,Downregulated
Feature0219,D-Raffinose isomer 2,C18 H32 O16,521.19563,NA,D-Raffinose isomer 2,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,26.58853075,22.70284879,0.853858718,-0.227930717,0.018514058,0.215273855,Downregulated
Feature0075,Pyrone isomer,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone isomer,5,4,2,0,0,0,0,0,0,0.8,0.4,0,60.3,4,2,0.666666667,0.75,2,Condensed HC,25.2215866,21.53335385,0.853766822,-0.228085995,0.018493629,0.215273855,Downregulated
Feature0431,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,17,0,0,5,0,0,0,1.64,0.68,0.32,51.18,8,-9,-4.666666667,-0.47826087,-14,Amino Sugar,24.63866599,20.96696986,0.85097829,-0.232805768,0.057038724,0.26375688,Downregulated
Feature0355,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,14,0,0,1,0,2,0,1.678571429,0.5,-0.928571429,86.76428571,7,-7,-0.909090909,-0.166666667,-10,Protein,24.83294571,20.98963296,0.845233312,-0.242578467,0.116901031,0.309113303,Downregulated
Feature0157,Maltotetraose,C24 H42 O21,688.20401,NA,Maltotetraose,24,42,21,0,0,0,0,0,0,1.75,0.875,0,60.3,4,-17,-5.666666667,-0.481481481,-17,Carbohydrate,24.84247343,20.94724945,0.843203054,-0.246048003,0.071217118,0.26375688,Downregulated
Feature0481,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,11,0,0,1,0,0,0,1.642857143,0.785714286,0.142857143,56.22857143,4,-7,-4,-0.333333333,-8,Carbohydrate,24.77859862,20.83549487,0.840866555,-0.25005123,0.068044205,0.26375688,Downregulated
Feature0468,"[Similar to: (3R)-4,4-Dimethyl-2-oxotetrahydro-3-furanyl beta-D-glucopyranoside; ΔMass: 49.0164 Da]",C13 H19 N5 O6,341.13224,Metabolic pathways;Other,"[Similar to: (3R)-4,4-Dimethyl-2-oxotetrahydro-3-furanyl beta-D-glucopyranoside; ΔMass: 49.0164 Da]",13,19,6,0,0,5,0,0,0,1.461538462,0.461538462,0.615384615,42.76153846,7,1,-2,-0.2,-4,Phenol,27.49735919,23.05474504,0.83843488,-0.254229359,0.019009893,0.215273855,Downregulated
Feature0262,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,0,0,0,5,0,0,0,1,0,2,3.3,6,6,Inf,Inf,1,Unsaturated HC,26.01754093,21.7851021,0.837323641,-0.256142736,0.030829149,0.246524182,Downregulated
Feature0247,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,10,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,3,-7,-3.5,-0.285714286,-7,Carbohydrate,27.43877117,22.86140606,0.833178932,-0.263301736,0.018016679,0.215273855,Downregulated
Feature0195,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,0,0,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.294117647,2,Lipid,24.59349877,20.48131732,0.832793963,-0.263968484,0.2236744,0.428644321,Downregulated
Feature0446,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,8,0,0,5,0,0,0,1.526315789,0.421052632,0.105263158,57.3,8,0,-0.833333333,-0.1,-5,Protein,25.83896637,21.48324519,0.831428196,-0.266336421,0.063068517,0.26375688,Downregulated
Feature0371,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,7,0,0,1,0,0,0,2.111111111,0.777777778,-0.222222222,66.63333333,1,-6,-7,-0.777777778,-7,Carbohydrate,26.74686121,22.22890341,0.831084561,-0.266932819,0.172915408,0.381941664,Downregulated
Feature0299,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,11,0,0,1,0,0,0,1.928571429,0.785714286,-0.142857143,64.37142857,2,-9,-5,-0.6,-10,Carbohydrate,24.47255265,20.32701663,0.830604675,-0.267766103,0.097747202,0.28444953,Downregulated
Feature0365,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,9,0,0,5,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.230769231,-6,Phenol,25.31299787,20.90781743,0.825971603,-0.275835912,0.009914214,0.181438821,Downregulated
Feature0108,NP-013538 mzCloud,C12 H16 O8,310.06652,NA,NP-013538 mzCloud-peak1,12,16,8,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,5,-3,-0.75,0.125,-3,Other,24.84293971,20.50243715,0.825282249,-0.277040485,0.102794186,0.28953887,Downregulated
Feature0194,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,1,0,0,4,0,0,0,0.8,0.2,2,3.3,6,5,Inf,3,1,Condensed HC,26.14391472,21.56590829,0.824892084,-0.277722703,0.015487936,0.215273855,Downregulated
Feature0414,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,25.31024468,20.86809673,0.824492098,-0.278422428,0.099805331,0.285900687,Downregulated
Feature0056,NA,NA,283.10322,NA,Feature0056,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.95721761,21.31506195,0.821161276,-0.284262499,0.186030439,0.387582678,Downregulated
Feature0415,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,25.54974006,20.95960647,0.820345194,-0.285696984,0.074098208,0.26375688,Downregulated
Feature0416,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,24.64831995,20.20614035,0.819777591,-0.286695542,0.07110826,0.26375688,Downregulated
Feature0370,[Similar to: methyl N-acetylneuraminate],C12 H21 N O9,323.12167,NA,[Similar to: methyl N-acetylneuraminate]-peak2,12,21,9,0,0,1,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.384615385,-7,Carbohydrate,25.83732156,21.17060943,0.819380963,-0.28739372,0.068287172,0.26375688,Downregulated
Feature0368,[Similar to: Muramic acid; ΔMass: 144.0422 Da],C16 H21 N5 O7,395.14274,NA,[Similar to: Muramic acid; ΔMass: 144.0422 Da],16,21,7,0,0,5,0,0,0,1.3125,0.4375,0.5,46.05,9,2,-0.75,0.066666667,-3,Phenol,25.48494519,20.84128742,0.817788199,-0.290200851,0.010577888,0.181807449,Downregulated
Feature0030,NA,NA,281.08757,NA,Feature0030,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.16101685,19.75284396,0.817550192,-0.290620791,0.055030124,0.26375688,Downregulated
Feature0470,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,16,0,0,6,0,0,0,1.363636364,0.727272727,0.909090909,34.39090909,11,-5,#NAME?,-0.375,-11,Other,25.87004312,21.0955083,0.815441559,-0.294346608,0.078833962,0.26375688,Downregulated
Feature0120,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,3,0,0,2,0,0,0,2,0.428571429,-0.285714286,68.44285714,2,-1,-1.5,-0.428571429,-3,Protein,25.85511226,21.07425687,0.815090519,-0.294967809,0.085245987,0.272814166,Downregulated
Feature0069,NA,NA,310.06652,NA,Feature0069,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.8681925,20.21059236,0.812708538,-0.299190045,0.059519187,0.26375688,Downregulated
Feature0471,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,16,0,0,6,0,0,0,1.363636364,0.727272727,0.909090909,34.39090909,11,-5,#NAME?,-0.375,-11,Other,26.04123673,21.0390125,0.807911418,-0.307730974,0.077207823,0.26375688,Downregulated
Feature0430,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,13,0,0,1,0,0,1,1.823529412,0.764705882,0,60.3,3,-10,-6,-0.647058824,-12,Carbohydrate,24.34949686,19.63568974,0.806410492,-0.310413686,0.068935776,0.26375688,Downregulated
Feature0508,NA,C16 H28 N2 O13,456.15919,NA,Feature0508,16,28,13,0,0,2,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,24.54561298,19.67076852,0.801396508,-0.319411872,0.072447422,0.26375688,Downregulated
Feature0506,NA,C22 H39 N O17,589.22211,NA,Feature0506,22,39,17,0,0,1,0,0,0,1.772727273,0.772727273,-0.090909091,62.89090909,4,-13,-3.5,-0.44,-14,Carbohydrate,25.0025168,20.00081713,0.799952152,-0.322014384,0.03855238,0.255467577,Downregulated
Feature0531,NA,C16 H29 N O13,443.16395,NA,Feature0531,16,29,13,0,0,1,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.529411765,-11,Carbohydrate,24.97556344,19.93994194,0.798378062,-0.324856017,0.03515159,0.247834554,Downregulated
Feature0404,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,12,0,0,1,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.333333333,-0.444444444,-10,Carbohydrate,25.75270446,20.45802985,0.794403162,-0.33205673,0.060152083,0.26375688,Downregulated
Feature0386,[Similar to: Hypoxanthine],C5 H4 N4 O,136.03851,Metabolic pathways;Other,[Similar to: Hypoxanthine],5,4,1,0,0,4,0,0,0,0.8,0.2,2,3.3,6,5,Inf,3,1,Condensed HC,26.41645244,20.97397415,0.793973914,-0.332836486,0.010226552,0.181438821,Downregulated
Feature0338,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,13,0,0,1,0,0,0,1.823529412,0.764705882,-0.117647059,63.65294118,3,-10,-3.666666667,-0.473684211,-11,Carbohydrate,25.95538801,20.49389485,0.789581525,-0.340839861,0.012031007,0.196060858,Downregulated
Feature0445,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,12,0,0,1,0,0,0,1.476190476,0.571428571,-0.19047619,65.72857143,7,-5,-0.75,0,-6,Phenol,25.23468761,19.82327513,0.785556589,-0.348212888,0.033280263,0.246800495,Downregulated
Feature0519,NA,C22 H23 N3 O5,431.14036,NA,Feature0519,22,23,5,0,0,3,0,0,0,1.045454545,0.227272727,-0.181818182,65.48181818,13,8,0.357142857,0.454545455,5,Phenol,25.25354651,19.82766304,0.785143704,-0.348971362,0.060075218,0.26375688,Downregulated
Feature0105,NP-015114 mzCloud,C11 H19 N O6,278.14781,NA,NP-015114 mzCloud,11,19,6,0,0,1,0,0,0,1.727272727,0.545454545,-0.363636364,70.66363636,3,-3,-1,-0.142857143,-4,Protein,25.4906366,19.79534681,0.776573262,-0.36480606,0.106093849,0.28953887,Downregulated
Feature0066,NA,NA,490.12991,NA,Feature0066,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.32545532,20.25258985,0.769315843,-0.378352076,0.027112461,0.244456611,Downregulated
Feature0339,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,7,0,0,0,0,2,0,1.333333333,0.291666667,-1.166666667,93.55,10,3,0.066666667,0.243243243,1,Phenol,26.04525944,19.91200016,0.764515332,-0.387382661,0.186039685,0.387582678,Downregulated
Feature0465,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,15,0,0,0,0,2,0,1.466666667,0.5,-0.8,83.1,10,-5,-0.538461538,0.024390244,-7,Phenol,25.09665977,19.09805119,0.760979802,-0.394069932,0.033828999,0.246800495,Downregulated
Feature0546,NA,C19 H22 Cl2 N6 O,420.12438,NA,Feature0546,20,22,1,0,0,6,2,0,0,1.1,0.05,-0.1,63.15,13,12,0.461538462,0.481481481,6,Unsaturated HC,25.60279398,19.41807921,0.758435943,-0.398900758,0.05705876,0.26375688,Downregulated
Feature0367,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,12,0,0,1,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,26.08203255,19.77165298,0.758056449,-0.399622812,0.001323264,0.067173118,Downregulated
Feature0348,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,18,0,0,4,0,0,0,1.6,0.72,0.32,51.18,8,-10,-4.666666667,-0.416666667,-14,Carbohydrate,26.56948778,20.02113983,0.753538796,-0.408246304,0.001101174,0.067173118,Downregulated
Feature0349,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,15,0,0,0,0,2,0,1.466666667,0.5,-0.8,83.1,10,-5,-0.538461538,0.024390244,-7,Phenol,25.68064453,19.30056992,0.751560962,-0.412037963,2.83E-04,0.040009735,Downregulated
Feature0189,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,8,0,0,4,0,1,0,1.3,0.8,1,31.8,7,-1,2,-2,-6,Other,25.15179187,18.89611099,0.751282894,-0.412571841,0.071247991,0.26375688,Downregulated
Feature0050,NA,NA,297.08247,NA,Feature0050,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.75535575,18.54305279,0.749052164,-0.416861904,0.066216345,0.26375688,Downregulated
Feature0447,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,7,0,0,1,0,0,0,2.090909091,0.636363636,-0.545454545,75.84545455,1,-6,-2.333333333,-0.538461538,-7,Amino Sugar,24.98479586,18.4047784,0.736639135,-0.440970051,0.005853119,0.155920123,Downregulated
Feature0469,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,18,0,0,5,0,0,0,1.72,0.72,0.32,51.18,7,-11,-8,-0.636363636,-16,Carbohydrate,26.28171712,18.75006621,0.713426224,-0.487163848,9.36E-04,0.064342267,Downregulated